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ABSTRACT
Cholera toxin (molecular weight 84kD) binds with high affinity (K^ =
10-9M) to GM-l ganglioside on the outer surface of most eukaryotic
cells before all or part of the molecule is internalised and activation of
adenylate cyclase occurs. The GM-|_ ganglioside is believed to diffuse
laterally on the cell surface. There is also evidence to suggest that
cholera toxin requires multivalent binding to GM^ before it can activate
adenylate cyclase. The effect of cholera toxin binding on the lateral
diffusion of <3^ was examined using the Fluorescence Recovery after
Photobleaching technique either with fluorescently labelled toxin or with
inserted, fluorescently labelled GM-j^ ganglioside. Both toxin-receptor
complex and receptor alone showed the same percentage mobility (about
60-70%) on the surface of the NIH 3T3 cells (a fibroblast cell line) and
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both had a lateral diffusion coefficient of about 1 x 10 cm s .
This result shows that bound toxin mobility does not differ from inserted
ganglioside mobility. An interpretation of the results may be that
molecules were compartmentalized on the fibroblast cell surface into
mobile and immobile areas. The involvement of non-coated invaginations in
cholera toxin internalisation was confirmed by preliminary binding
experiments with colloidal gold conjugated cholera toxin. The cholera
toxin was also used as a probe to locate GM^ intracellularly by the
Post-Embedding Immunogold technique on mouse small intestine (target
tissue for cholera toxin). A previously unreported, specific binding to
the heterochromatin of the nucleus of mouse intestinal cell was
discovered. The intracellular localisation of GM-j, has previously mainly
been studied by cell fractionation studies which indicated that only a
small amount of total cell ganglioside is found within the nucleus. This
binding of cholera toxin to the nucleus was further investigated using
biochemical binding studies which also appeared to indicate a specific
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1.1.0 BACKGROUND: CHOTFTRA TOYTN
It was not until 1969 that cholera enterotoxin was isolated by Finkelstein
et al., over a century after the comma-shaped bacterium Vibrio cholerae
had been identified by Paccinni (see Pollitzer, 1965). The symptoms of
the disease are a massive diarrhoea, often followed by vomiting, which can
deplete the victim of up to twenty-five per cent of body fluids and
essential salts within hours. The most common cause of death is an
intense peripheral vasoconstriction (De, 1961).
The V. cholerae are spread by human excrement in contaminated drinking
water. The bacteria thrive in the digestive tract, where they produce the
protein enterotoxin, which is now known to be a major cause of the disease
symptoms. Thanks to the great improvement in sanitation, the disease has
been eradicated in developed countries, but it is still a major killer in
the Third World (Garfield, 1986).
Although the toxin molecule has been very widely studied, the details of
its mechanism of action on the gut remain obscure.
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1.1.1 Nature of the Toxin
Cholera toxin is a globular protein, with a molecular weight of about
84 000 Daltons, containing no appreciable amount of lipid or sugar.
(Sattler et al., 1975; LoSpalluto and Finkelstein, 1972; van Heyningen,
1976). The toxin molecule has an isoelectric point of 6.9 and has a very
stable structure, maintaining its activity even after boiling in sodium
dodecyl sulphate (Lai, 1980).
Often secreted with cholera toxin is a non toxic protein termed
choleragenoid, which has a molecular weight of about 55 000 Daltons and is
an incomplete cholera toxin molecule. The function of choleragenoid, if
any, is unknown.
1.1.1.1 Subunit Structure of the Toxin
Initial analysis of the toxin molecule by SDS polyacrylamide gel
electrophoresis showed that it is composed of two non-covalently linked
subunits termed A and B (Finkelstein et al., 1972). Molecular weight
determinations of each of the subunits and the whole toxin suggested a
molar ratio of five B subunits to every A subunit (Lai et al., 1977).




Diagrammatic representation of a cholera toxin molecule (drawn roughly to

















Electron microscopy also supports the evidence for the molar ratio of B
subunits (Sigler et al., 1977). X-ray crystallography suggests a
pentameric doughnut-shaped structure for the B subunit bound to lipid, the
outer ring having a diameter of 60 Angstroms and the inner ring 20
Angstroms (Iiidwig et al., 1986).
The A subunit consists of two polypeptide chains initially secreted as a
single polypeptide chain, which is nicked by bacterial proteases after
secretion of the cholera toxin (Gill and Rappaport, 1979; Mekalanos et
al., 1979). The two chains A-^ (22 000 Da) and A2 (7 000 Da) are
linked by a disulphide bond, and are non-covalently associated with the B
subunits (Gill, 1976; van Heyningen, 1976, 1977; Ribi et al., 1988). (See
fig. 1.1 for a diagrammatic representation of the cholera toxin molecule).
Each subunit plays a different role in the action of the toxin. Van
Heyningen (1976) showed that the function of the B subunit was to bind to
the cell membrane receptor and that the A subunit possessed the toxic
enzymic activity of the toxin. This explained an earlier observation that
choleragenoid, the naturally occuring aggregate of B would protect cells
(by competing for the receptor) and even intact loops of gut (Pierce,
1973) from subsequent challenge with toxin (Holmgren et al., 1974; Gill
and King, 1975).
The activity of subunit A was not affected by ganglioside preincubation,
and all the activity was found specifically in the A^ peptide (van
Heyningen, 1976). This indicated that the A subunit played no role in the
binding of the toxin to the cell surface receptor.
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The B subunit has been completely sequenced (Nakashima et al., 1976; Lai
et al., 1977) and the first forty residues shew a significant similarity
to the epsilon chains (which bind to the cell receptor) of glycoprotein
hormones such as thyrotropin, luteinizing hormone, human chorionic
gonadotropin and follicle stimulating hormone (Ledley et al., 1976;
Kurosky et al., 1977). A secondary structure prediction has been made for
subunit B (Duffy and Lai, 1979) based on the method of Chou and Fasman
(1978). The molecule shews as much as 35% helical content. The A subunit
has also been fully sequenced at the DNA level (Mekalanos et al., 1983) a
partial amino acid sequence is known (Jacobs et al., 1974; Lai et al.,
1979; Duffy et al., 1981).
1.1.2 Mechanism of Toxicity
Unlike other bacterial toxins such as diphtheria toxin (Uchida, 1982)
cholera toxin is not cytotoxic, yet it has profound effects on intestinal
cells, resulting in a massive efflux of electrolytes which is indirectly
responsible for the symptoms of cholera almost certainly due to an
elevation of cyclic AMP from activated adenylate cyclase (Lai, 1980).
The toxin also has effects on other cell types. Glycogenolysis is
promoted by the toxin in liver cells and platelets (Zieve et al., 1971).
The rate of lipolysis has been shown to be proportional to the amount of
toxin added to fat cells (Greenhough et al., 1970; Cuatrecasas, 1973c).
Most of these effects are attributable to raised levels of cyclic AMP.
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However, more recent studies have shewn that some of the toxin's effects
appear to be mediated by cAMP independent mechanisms (Aranda and Samuels,
1984; Imboden et al., 1986). Cholera toxin was shown to decrease thyroid
hormone nuclear receptors in cultured cells, in a time and
dose-dependant fashion. The decrease in the number of receptors did not
correlate with the amount of cAMP induced by the toxin. Furthermore, in
the same cells forskolin, which is able to increase cAMP levels up to
500-fold, had no effect on the number of nuclear thyroid hormone
receptors. Aranda and Samuels (1984) proposed that the toxin was somehow
decreasing receptor synthesis by a cAMP independent mechanism.
Imboden (1986) showed that exposure of the malignant human T-cell line
Jurkat to cholera toxin for three hours reduced the antigen receptor
number on the cells. This effect could not be mimicked by the B subunit
alone (indicating that mere binding was not enough to produce the effect)
or by incubating the cells with reagents to increase cAMP levels.
There are believed to be three basic steps in the toxic action of the
cholera toxin molecule. These are;
1. Binding of the toxin to the cell surface.
2. Internalisation of part or all of the toxin molecule.
3. Activation of the adenylate cyclase enzyme.
In order to examine each step of the mechanism in detail, they will be
described separately. Fig. 1.2 gives a summary of the steps of
intoxication by cholera toxin.
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1.1.2.1 Binding of the Toxin to the Cell Surface
There is little doubt that ganglioside GM-^ (see section 1.2.4) is the
major receptor for cholera toxin on the cell surface (Cuatrecasas, 1973b;
Holmgren et al., 1975; Mass et al., 1976b; Reed et al., 1980). There is a
strong specificity of cholera toxin for GM-j_ ganglioside; other
gangliosides bind very much less tightly and do not inhibit the binding of
the toxin to the cell surface to the same extent (King and van Heyningen,
1973; Staerk et al., 1974).
Cholera toxin has therefore been used to locate and quantify GM-j^
ganglioside on different cells (Hansson et al., 1977; Ackerman et al.,
1980). The binding of the toxin to GJ^ is tight and irreversible with a
dissociation constant of about 10-9M (van Heyningen, 1983).
Nevertheless, it has been suggested that glycoproteins play a role in the
binding of cholera toxin to intestinal cells (Morita et al., 1980).
However, the evidence provided for glycoprotein binding was shown on a
fairly artificial system. Glycoproteins were extracted by lectin affinity
chromatography and run on SDS Page gels which were overlaid by iodinated
cholera toxin. Bound toxin was located by autoradiography. One cannot be
sure that the glycoproteins had the same conformation in situ and that
they were available for toxin binding in the membrane. In fact the authors
state that the presence of these glycoproteins alone is not sufficient




Summary of the Mechanism of Action of Cholera Toxin.













5) Penetration and "Activation"
of A Subunit
4) Dissociation and Entry
6) Activation of Cyclase
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Extensive studies involving direct extraction of the receptor from the
membranes did not confirm a possible glycoprotein receptor (Critchley et
al., 1981). No further evidence for a glycoprotein receptor has emerged
recently.
The interesting phenomenon of patching (grouping of cell surface molecules
into patches which does not require cellular energy) and capping
(accumulation of cell surface molecules at one pole of a cell which
requires cell metabolic energy) of either cholera toxin and/or GM-^ to
which it binds has been observed only on lymphocytes (Revesz and Greaves,
1975; Kellie et al., 1983; Speigel et al., 1984). The B subunit alone
also induced capping (Craig and Cuatrecasas, 1976; Sedlacek et al.,
1976). The redistribution of the surface bound cholera toxin or inserted
gangliosides to which cholera toxin had bound was observed at 37 °C and was
blocked by drugs which interfere with the cytoskeleton. These results
suggested that GM^ might be associated with a membrane-spanning protein
which interacted with the cytoskeleton.
GM-^ ganglioside itself cannot interact with the cytoskeleton as it is
too short, spanning only the upper leaflet of the bilayer. Further
support for the idea that GM-^ is associated, probably with a protein
linked to the cytoskeleton, has come from detergent extraction
experiments, which indicated that cholera toxin-GM-^ complexes remain
associated with the cytoskeleton under conditions which normally remove
the majority of plasma membrane lipids (Sahyoun et al., 1981; Streuli et
al., 1981).
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It has been shewn that multivalent binding of the toxin appears to be
essential for toxin action. Fishman and Atikaan (1980) correlated the
inhibition of adenylate cyclase activation, on different cell lines by
GM-L oligosaccharide addition with the density of cell receptors for
cholera toxin. Ihey concluded that multivalent binding of cholera toxin
was required for the adenylate cyclase activation to occur. The lateral
redistribution of the toxin that is sometimes observed may occur therefore
in order to achieve the full complement of five gangliosides bound to the
B subunit ring of a toxin molecule (Bennett and Cuatrecasas, 1976; Craig
and Cuatrecasas, 1976; Sahyoun and Cuatrecasas, 1975). Recently Ribi et
al. (1988) have shown that cholera toxin on an artificial bilayer binds
pentavalently to ganglioside.
1.1.2.1.1 Conformational Change on Binding?
When cholera toxin binds to GM1 the toxin alters its conformation and
direct evidence for such an event has come from different experimental
techniques.
The first observation was that a blue shift occurred in the intrinsic
protein fluorescence spectrum after the whole toxin or just its B subunit
had bound to ganglioside GM-^ (Mullin et al., 1976; Moss et al 1977a) or
to just the oligosaccharide portion of the ganglioside (Fishman et al.,
1978).
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This change in spectrum did not occur with any other ganglioside tested.
As intrinsic fluorescence of proteins is due primarily to tryptophan
residues, these experiments suggest a possible role of this residue in
binding of toxin to ganglioside. This binding role of tryptophan residues
is supported by the evidence from De Wolf et al. (1981) that modification
of the tryptophan residues with specific reagents prevented binding of the
B subunit to ganglioside in addition to the self-aggregation of the B
subunit alone.
Nuclear magnetic resonance has also indicated that binding of toxin to the
carbohydrate portion of GJy^ produces a change in the environment of the
tryptophan residue (Sillerud et al., 1981).
Therefore the conclusions from fluorescence, nuclear magnetic and
modification studies implicate a tryptophan residue in binding of the
toxin to its receptor and show that the toxin molecule undergoes a
conformational change.
In 1982, van Heyningen shewed that the conformational change in the B
subunit was transferred to the A subunit. In this experiment only A
subunit was labelled with Nbf-chloride (a fluorescent reagent) and binding
of GM-l to the toxin produced a change in the fluorescence spectrum of
the A subunit which reached a maximum when only one ganglioside was bound
per toxin molecule.
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The conformational change which occurs in the toxin molecule when it binds
to GM-^ is thought to be important in the insertion process of the active
A subunit into the cell (see section 1.1.2.2).
1.1.2.2 Internalisation of Part or All of the Toxin Molecule?
There is a time lag of 15-90 min, depending on the type of cell, between
binding of the toxin and activation of adenylate cyclase (Cuatrecasas,
1973a; Gill and King, 1975; Bennet and Cuatrecasas, 1975; Fishman, 1980).
If broken cells were incubated with toxin, no time lag was observed (van
Heyningen and King, 1975), which suggested either the involvement of a
membrane internalisation process or it might also represent a surface
lateral regrouping of cholera toxin receptors.
Over the last decade four theories have emerged for the internalisation of
cholera toxin which could account for this lag phase and they have tried
to provide an explanation as to how the active A-^ peptide reaches its
site of action, namely the regulatory component of the adenylate cyclase
enzyme complex (see section 1.1.2.3).
Gill (1976) hypothesised that the B subunits of the toxin formed a
hydrophilic channel, through which the A component could pass. Indeed
experiments with lipid bilayers shewed that the toxin could induce
permeability changes, perhaps indicating the formation of a pore or
channel (Moss et al., 1977b; Tosteson and Tosteson, 1978).
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In this model the time lag would be the time taken to form the channel and
for the A subunit to pass through. However, the above model has been
discounted by hydrophobic photolabel1ing experiments (Tomasi and
Montecucco, 1981; Wisnieski and Bramhall, 1981) and X-ray crystallography
(Ribi et al., 1988), which shew no evidence for penetration of the
membrane by the B subunits.
Another theory has been that cholera toxin undergoes receptor mediated
endocytocis, with processing in the lysosomes allowing dissociation of the
active subunit (Lin and Taniuchi, 1980; Houslay and Elliot, 1981; Janicot
and Desbuquois, 1987). In this model the time lag would be the time taken
for the toxin to be taken up and A-^ peptide to dissociate from the
endocytosed vesicle.
The hypothesis by Lin and Taniuchi (1980) was based on the fact that
lysosmotropic agents reduced the effects of the toxin on HeLa cells,
however in their experiments the toxin concentration was high and the
concentrations of chloroquine and methylamine used were greater than the
amounts needed to inhibit diphtheria toxin which is now believed to use
receptor-mediated endocytocis as its mode of entry (Olsnes and Pihl,
1982). In 1981 Gill et al. found that concentrations sufficient to
inhibit receptor mediated endocytosis had no effect on the action of
cholera toxin on Chinese hamster ovary cells. Therefore this mode of
entry might be non specific and occur only on account of the high toxin
concentration used.
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Fishman has studied the effects of lysosmotropic agents on choleragen
action fairly extensively and he states that their mechanism of action is
not clear (Fishman, 1982). Other workers have shown that these agents
also appear to interfere with ligand receptor clustering and
internalisation (Fitzgerald et al., 1980; Pastan and Willingham, 1981).
The theory that is becoming most widely accepted is that of A-^ peptide
penetration or translocation across the membrane (Fishman and Brady,
1976). Dissociation of the A-^ peptide from the whole toxin and its
subsequent internalisation might account for the observed time lag.
Binding of the toxin molecule would induce a conformational change in the
molecule (Fishman et al., 1978), so allowing penetration of the active
A-l peptide into the membrane thus perturbing it (Moss et al., 1976a;
1977b; Tosteson and Tosteson, 1978). Persuasive experimental evidence has
come from the hydrophobic photolabelling experiments of Tomasi and
Montecucco (1981) and Wisnieski and Bramhall (1981) who showed that the A
subunit was photolabelled by a lipid probe inside the membrane after the
toxin had bound to the surface. However, it is not clear whether the
whole A-^ polypeptide has to penetrate the membrane, as small proteolytic
fragments are claimed to show activity (Matuo et al., 1976; van Heyningen
and Tait, 1980).
Van Heyningen (1977) reported that cross-linked cholera toxin could
activate intact cells suggesting perhaps that the A-^ peptide did not
need to dissociate from the whole molecule.
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Ward et al. (1981) shewed that the peptide was not hydrophobic; that
it might not enter the lipid bilayer. So perhaps the A subunit just
penetrates the membrane and its active portion is placed near its site of
action at the regulatory subunit of adenylate cyclase.
The simplest theory of internalisation was originally suggested by van
Heyningen and King in 1975, based on their observation that subunit A was
active alone even with intact cells, although at low specific activity.
The high local concentration of toxin after binding GM^ may result in
random entry of a few active toxin molecules, which is all that are needed
for maximal activation of cyclase. The time required for dissociation of
the A1 peptide and then its internalisation would account for the
observed time lag.
1.1.2.3 Activation of Adenylate cyclase
The mechanism of activation of the adenylate cyclase enzyme is quite well
understood. It was Gill who first reported that NAD+ is required for
cholera toxin activation of adenylate cyclase (Gill, 1975; 1976). Moss et
al. (1977a) discovered that cholera toxin catalysed the hydrolysis of
NAD+ to ADP-ribose and nicotinamide and Moss and Vaughan (1977) later
shewed that the same reaction was stimulated by the presence of D or L
arginine or guanidine which acted as acceptors for the ADP-ribose moiety.
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In pigeon erythrocytes, when [ HP]-NAD was supplied, cholera toxin
catalysed the ADP-rihosylation of specific proteins (Gill and Meren, 1978;
Cassel and Pfeuffer, 1978; Gill 1979). The main protein which was
affected by the toxin was a 42 000 dalton protein identified as the
regulatory protein N (of the adenylate cyclase enzyme) by Pfeuffer in
1977.
Substantial evidence has emerged to show that the regulatory component of
adenylate cyclase (which binds guanine nucleotides) couples the hormone
receptor to the catalytic subunit, which synthesises cyclic AMP (reviewed
by Ross and Gilman, 1980; Rodbell, 1980).
Cassel et al. (1977) showed that ADP ribosylation of the regulatory
protein Ns of adenylate cyclase prevented the GTP bound to it from
becoming hydrolysed thus deactivating the enzyme. In effect it maintained
the active state of the enzyme.
All the above points may be summarised in a schematic representation of
cholera toxin activation of adenylate cyclase (See fig. 1.3).
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Fia.1.3
Activation of the Adenylate Cyclase Enzyme by Cholera Toxin.
(Reproduced from van Heyningen, 1977).
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1.1.3 Other Bacterial Toxins and Plant Toxins
Cholera toxin is very similar to the heat-labile enterotoxin produced by
Escherichia coli which produces the milder symptoms of 'travellers
diarrhoea* in humans. Hie two toxins share extensive immunological
cross-reactivity (Clements and Finkelstein, 1978; Lindholm et al., 1980).
Both toxins have ADP-ribosyltransferase activity and they both
irreversibly activate adenylate cyclase through covalent modification of
the GTP-binding regulatory subunit (Gill and Richardson, 1980).
Furthermore, the two toxins have the same subunit structure (Clements et
al., 1980) and show much sequence homology (Mosley and Falkow, 1980;
Spicer et al., 1981; Spicer and Noble, 1982; Dykes et al., 1985). There
is an indication however, that the two toxins show subtle differences in
their binding characteristics, stemming from the observation that E.coli
heat-labile toxin has a relatively high affinity for galactose polymers
and can be purified on agarose columns, whereas the binding of cholera
toxin to these columns is weak (Clements and Finkelstein, 1979; Clements
et al., 1980).
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Several other bacterial toxins which are responsible for quite different
diseases with very different metabolic effects on cells shew distinct
similarities in their attack on cells. Hie main similarities may be seen
in their structure, their binding to cells and their mode of action.
1.1.3.1 Similarities in Structure
Bacterial toxins have the common problem of approaching cells from the
outside and acting on intracellular targets. Hence the toxins have
adopted the successful strategy of having a binding component which
recognises the cell surface and an active component whose entry into the
cell is assisted by the binding component.
Cholera toxin structure has been mentioned, as has that of E.coli heat
labile toxin, which is essentially the same. Diptheria toxin secreted by
Corvnebacterium diphtheriae has an essentially similar structure to
cholera toxin having 2 chains (Collier, 1975; Pappenheimer, 1977; Uchida,
1982). It is secreted as a single polypeptide that can be proteolytically
cleaved into two chains, fragment A (24 000 Da) and fragment B (38 000 Da)
which remain connected by a disulphide bond. The B fragment bonds to an
unknown receptor, which might be the anion transporter (Olsnes and
Sandvig, 1986), and this allows the active A fragment to enter the cell.
Less is known about the Clostridium neurotoxins tetanus secreted by
Clostridium tetani and botulinum secreted by Clostridium botulinum.
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Both are secreted as single polypeptide chains of about 150 000 Da and
both are proteolytically nicked to form two chains of about 100 000 Da and
50 000 Da joined by one or more disulphide bonds. Again, one of the
chains, the heavier one, shows binding activity. By analogy to the other
bacterial toxins, although no activity is kncwn, the active domain is
believed to reside in the light chain (van Heyningen, 1980; Sugiyama,
1980; Mellanby and Green, 1981). The toxin which causes whooping cough,
pertussis secreted by Bordetella pertussis has also been shown to have
several binding components and an active component, like cholera toxin
(Tamura et al., 1982).
The plant toxins, abrin, ricin and modeccin all have both a binding chain
and an active chain (Olsnes and Pihl, 1976; 1982).
1.1.3.2 Similarities in Binding
The two major cell surface components implicated in the binding of
bacterial toxins have been glycolipids and glycoproteins. These cell
surface components are termed receptors, yet they are not 'true' receptors
in an endocrinological sense, whereby just the binding of the ligand
causes the receptor to initiate the physiological response. Indeed it has
also been shown recently that diphtheria toxin remains toxic to cells even
if its binding component is replaced by another molecule which recognises
the cell surface thereby discounting the need for a specific receptor
molecule for the ligand (Johnson et al., 1988).
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It has been shewn that GM-^ ganglioside is the major receptor for cholera
toxin, (see section 2.2.0). E.coli heat-labile toxin has also been shown
to bind GM-^ ganglioside (Svennerholm and Holmgren, 1978; Moss et al.,
1979,1981). However there is some evidence for a galacto protein receptor
for the E. coli toxin (Griffiths et al., 1986), as E. coli toxin cannot
compete out cholera toxin binding 100%.
Although, as mentioned previously, it has been shown that the diphtheria
toxin receptor is not needed for diphtheria toxin to exert its toxicity on
cells, provided the active subunit is attached to another cell surface
recognising ligand, there is evidence that the usual receptor might be a
protein. This has been reviewed by Eidels et al. (1983). It has been
suggested that it is the anion transporter (Olsnes and Sandvig, 1986).
Both botulinum and tetanias toxins are believed to bind to a ganglioside
molecule, possibly GT-q-, or GD-^ (Holmgren et al., 1980; Kitamura et
al., 1980). There is little information on the nature of the receptor for
pertussis toxin. However, it may be a molecule containing sialic acid, as
the B protomer of the toxin binds to the sialoprotein haptoglobinin (Irons
and Maclennan, 1979; Tamura et al., 1982).
Finally, it has been shown that the plant toxin ricin, binds to plasma
membrane molecules with terminal galactose residues (Pardoe et al., 1969;
Baenziger and Fiete, 1979; Sandvig et al., 1976).
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1.1.3.3 Similarities in Mode of Action
To date, at least five bacterial toxins are known to share the same
enzymic reaction: catalysis of the cleavage of NAD+ and ADP-ribosylation
of a protein substrate.
Both cholera toxin and E. coli IT toxin act on the GTP-binding regulate
subunit which stimulates adenylate cyclase (Gill and Richardson, 1980).
Pertussis toxin, however, acts on the GTP binding regulatory subunit Gi
which inactivates adenylate cyclase (Bokoch et al., 1983). The site of
action of diphtheria toxin is the protein elongating factor 2 (EF2) which
is necessary in protein synthesis and its ADP-ribosylation eventually
leads to the death of the cell (Collier, 1975; Pappenheimer, 1977; Uchida,
1982) .
The molecular action of the plant toxins is to modify one or two
nucleotides on 28s rRNA (Endo et al., 1987) and thus prevent protein
synthesis (Olsnes and Pihl, 1982). As yet, no molecular action has been
determined for tetanus and botulinum toxins.
It is therefore evident that bacterial and plant toxins have many
properties in common. (See Table 1 for a summary of these similarities
and differences).
Table1SimilaritiesandDiffe encesBetw enTox s
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In 1935, Professor E. KLenk of Cologne University found a type of
glycosphingolipid containing an unknown acidic sugar (sialic acid), in the
brain tissue of children suffering from infantile amaurotic idiocy (Tay
Sachs disease). These lipids had been detected earlier by Landsteiner and
Levene (1925) and Walz (1927 a, b) by their reaction with
p-dimethylaminobenzaldehyde and orcinol to form a coloured complex. In
1942, KLenk named this type of glycosphingo-lipid, 'ganglioside', as he
thought that it was located in ganglion cells. However, in 1951, Yamakawa
and Suzuki discovered that ganglioside also occurred in extraneural tissue
and fluids.
Gangliosides are the most complex of brain lipids. They are a group of
glycosphingolipids characterised by the presence of N-acetyl or
N-glycolyl-D neuraminic acid and a variety of other sugars, e.g. glucose,
galactose and N-acetyl galactosamine (Kuhn and Wiegandt, 1963). At least
40 different ganglioside structures have been established during the last
twenty years (Hakkinen and Kulonen, 1963; Svennerholm, 1963; Tettamenti et
al., 1964; Hakamori, 1966; Ando and Yu, 1979) and this number approaches
60 when variation in sialic acid is taken into account (Ledeen, 1983). In
addition to variation in type of ganglioside, large differences occur in
ganglioside concentrations for different tissues (Ledeen and Yu, 1982).
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1.2.1 Structure
Gangliosides are compounds that are hydrophilic at one end of the molecule
and hydrophobic at the other. They also have a strong negative charge,
due to the presence of one or more sialic acid residue. The hydrophobic
end of the molecule consists of two long chain fatty acids which are
linked to the amino alcohol sphingosine. The hydrophilic end is mainly
carbohydrate, consisting of molecules of hexoses, N-acetyl hexosamines and
sialic acid residues. A more detailed description of ganglioside
structure may be obtained from the review by Ledeen and Yu, 1982.
The nomenclature of gangliosides is based primarily on the number of
sialic acid residues and the carbohydrates which form the oligo¬
saccharide portion of the molecule. Therefore the letter G stands or
ganglioside. M denotes monosialo-one sialic acid; D = disialo-two sialic
acids; and T = trisialo-three sialic acids etc. The numbers written as a
subscript stand for; 1, the major neutral tetrasaccharide chain, 2, the
chain lacking the terminal galactose and 3, for the chain lacking
galactosyl-N-galactosamine (Svennerholm, 1970).
Thus, the majority of mammalian gangliosides are based upon GM-l as the
basic structural unit (Ledeen and Yu, 1982). This unit is ceramide
glucose-galactose, (sialic acid attached) - N-acetyl
galactosamine-galactose (See fig. 1.4).
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The ceramide portion is believed to be inserted in the upper leaflet of
the lipid bilayer and the oligosaccharide head is exposed (Hakamori,
1981).
1.2.2 Biosynthesis
The biosynthesis of gangliosides will be covered very briefly, dealing
only with the hydrophilic carbohydrate portion of the structure and not
the ceramide as it is the oligosaccharide end of the molecule which
appears to interact with the bacterial protein cholera toxin.
Addition of monosaccharides to the ceramide is catalysed by glycosyl-
transferases. Each reaction involves the transfer of a sugar residue from
a donor to an acceptor. The addition is ordered and each glyco-
syltransferase is highly specific. The pathway for the biosynthesis of
the major gangliosides has been worked out in detail (Roseman, 1970;
Fishman and Brady, 1976; Basu et al., 1976, 1979). See fig. 1.5 for an
outline of this biosynthetic pathway for the major mammalian gangliosides.
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Fig. 1.4
Structure of GM^ ganglioside
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1.2.2.1 Cellular localisation of Glvcosvltransferase
The localisation of glycosyltransferases within cells is a little
controversial. Keenan et al. (1974) demonstrated that in human liver,
these enzymes are associated with the golgi apparatus. In cultured cells,
it has been shown that there is some enzyme activity in the plasma
membrane (Reviewed by Shur and Roth, 1975).
1.2.2.2 Cellular Distribution of Gamliosides
It was originally assumed that all gangliosides in non-neuronal cells were
located in the plasma membrane (see review by Stoffel, 1971). However,
Keenan and co workers showed that for rat liver and bovine mammary gland,
only 10 to 25% of the total cellular gangliosides were located in the
plasma membrane, the rest being distributed amongst the intracellular
membranes (Keenan et al., 1972 a, b). When the biosynthesis of
gangliosides in cultured cells was examined, most of the gangliosides were
found on the cell surface, with some in lysosomes, others at the golgi,
and the rest being in transit from the golgi to the plasma membrane
(Miller-Prodraza et al., 1982).
More recently, Matyas and Morre (1987) have extended the original work by
Keenan et al., (1972) and specified the individual gangliosides in highly
purified membrane fractions from rat liver. They found that individual
gangliosides were non-homogeneously distributed and that each membrane
fraction could be characterised by a unique ganglioside composition.
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Hie membranes they examined were plasma, nuclear, golgi and endoplasmic
reticulum.
Spiegel et al. (1988) found an asymmetric distribution of gangliosides in
rat renal brush-border and basolateral membranes and suggested that this
indicated a specific sorting mechanism for epithelial plasma membrane
glycolipids, and that this might be linked to their possible functional
roles in each of the membranes. Thus, relatively little information has
been accumulated about the localisation of ganglioside molecules within
cells. It is becoming evident that the plasma membrane is not the only




Summary of the major pathway of carbohydrate addition in ganglioside
biosynthesis.




Gangliosides have been implicated in a variety of cellular phenomena but
their exact physiological role remains unknown. The large variety of
glycosphingolipid types suggest they are well suited to interact with
exogenous ligands or regulate protein receptor function, due to their
carbohydrate being exposed and their lipid being inserted within the
membrane (Nagai and Iwamori, 1980). Structural rigidity might be
conferred on the membrane by the high content of ganglioside present
within the bilayer.
1.2.3.1 Structural Rigidity of Membranes
It has been shown using the sensitive technigues of nuclear magnetic
resonance and electron spin resonance spectroscopy that liposomes
containing sphingolipids are more rigid than those with just phospholipids
(Abrahamsson et al., 1977; Sharom and Grant, 1977). An explanation of
this was given by Yamakawa and Nagai in 1978, who suggested that
glycosphingol ipids had both hydrogen acceptors and a variety of hydrogen
donors, so they could make stable hydrogen bond interactions and have a
more rigid and ordered region in membranes than phospholipids which had
only hydrogen acceptors and thus could not undergo the same interaction.
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1.2.3.2 Cell Differentiation and Growth Markers
Ganglioside patterns and quantities alter considerably during development
of the brain (Suzuki, 1965; Dreyfus et al., 1975). Recently Facci et al.,
(1988) demonstrated that both endogenous and exogenous gangliosides could
influence the state of differentiation of astroglial cells, in vitro.
Transformed cells lack the growth restraints in culture which arise as a
result of cell contact or density changes. They have a reduced
requirement for nutrients and they have a different morphology to normal
cells. As a most striking change occurs in their ganglioside pattern and
synthesis, it is thought that the alteration in growth characteristics of
the transformed cells may be related to this change in gangliosides (Brady
and Fishman, 1974; Hakamori, 1975). Indeed some gangliosides such as
GD-y-, have been found to be important specific oncogenic markers (Feizi,
1985).
The role of endogenous and exogenously added gangliosides is being
increasingly studied (Alessandri et al., 1987; Spiegel and Fishman, 1987,
Hanai et al., 1987). The work by Spiegel suggests a possible modulatory
role of gangliosides on a signal transduction mechanism activated by
exogenously applied growth factors.
1.2.3.3 Interaction with Biologically Active Factors
Gangliosides have been implicated as receptors for a wide range of
biologically active factors, which will be dealt with very briefly here.
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Hie term receptor here is only used to indicate that gangliosides have
been shown to have specific binding interactions with certain ligands.
GMj is the receptor for cholera toxin (see Section 1.2.4). Gangliosides
have also been implicated as receptors for other bacterial toxins (see
Section 1.1.3.2). They have also been shewn to interact with glycoprotein
hormones and viruses. These interactions have been reviewed by Hakomori,
1981.
1.2.4.0 Evidence that (34-^ is the Receptor for Cholera Toxin
In 1971, van Heyningen and co workers showed that by preincubating cholera
toxin with a crude ganglioside mixture they could prevent cholera toxin
binding to cells. Two years later, three independent studies first
recognised GM-j^ as the probable cell surface receptor for cholera toxin
(Holmgren et al., 1973; Cuatrecasas, 1973b; King and van Heyningen,
1973). Holmgren's group showed that GM-j_ inhibited the effects of
cholera toxin down to equimolar concentrations. They also showed that two
other glycol ipids ie. GDla and GA1 reacted with the toxin yet they
only inhibited cholera toxin when at 500 times greater concentration than
(34-1^. The same group also showed that only GM-l gave rise to a
precipitation band, in an Ouchterlony-type (Ouchterlony, 1958) double
diffusion test, giving direct evidence for specific binding between the
multivalent toxin and <34-^ (probably in micelles) in a system independent
of biological assays.
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Studies with various cell types, including small intestinal mucosal cells
from different species, demonstrated a direct relationship between the
cell content of GM^ and the number of toxin molecules the cell could
bind (Holmgren et al., 1975; Hansson et al., 1977).
Mullin et al. (1976) observed that pretreatment of cell membranes with
cholera toxin specifically blocked the membrane GM^ ganglioside from
reacting with galactose oxidase. Exposure of several cell lines to sodium
butyrate (an agent which induces differentiation in cells) increased the
amount of GM^ in the membranes, with a concomitant increase in the
number of toxin receptors (Fishman and Atikaan, 1979).
A very strong support for the receptor role of GM^ comes from
experiments showing that exogenous QV^ can be incorporated into the cell
membrane and then act as a functional receptor. This was first
demonstrated by Cuatrecasas (1973b) who observed increased binding
capacity and lipolytic responsiveness of fat cells which had been exposed
to GMj.
Moss et al. (1976b) added [3H]-GM1 to a cell line (NCTC 2071) grown in
a chemically defined medium without serum (as serum contains trace amounts
of ganglioside). Normally these cells lack any detectable GM^ but they
do have an adenylate cyclase enzyme so only broken cell preparations can
respond to cholera toxin.
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In this experiment, the intact cells took up the ganglioside and exhibited
a response to cholera toxin, which was maximal when 100 000 molecules of
GM^ had been incorporated per cell. These cells could also take up
other gangliosides, but were not sensitised to cholera toxin when they did
(Fishman et al., 1976, Fishman, 1982).
Several other studies have also shown that exogenously added gangliosides,
especially GM-^, can stably insert into the plasma membrane and behave as
a functional receptor for cholera toxin and are then metabolised by the
cell (Spiegel et al., 1983; Fishman et al., 1983).
Spiegel showed that even fluorescent derivatives of GM1 ganglioside can
stably insert into a cell membrane (glioma cell line lacking toxin
receptors) and act as a toxin receptor, so, increasing the capacity of the
cell to bind toxin and also increasing the level of activation of
adenylate cyclase (Speigel, 1985). Therefore, fluorescent ganglioside
derivatives have become very important tools in the study of ganglioside
function in cells.
Several other lines of evidence support GM-^ as the receptor for cholera
toxin. All toxin binding activity on cells and membranes which had been
exhaustively delipidated, was removed (Cuatrecasas, 1973a, Fishman and
Atikaan, 1979; Critchley et al., 1981).
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A protein receptor does not appear to be implicated in cholera toxin
binding as proteases do not affect it (Cuatrecasas, 1973a; Fishman and
Atikaan, 1979; Critchley et al., 1981). Critchley, 1981 showed very
clearly with intestinal lipid extracts separated on thin-layer silica gel
and overlayed with 125I-labelled cholera toxin, that the toxin bound
only to material corresponding to GT^. He also showed that if
intestinal membranes were dissolved in SDS and separated by
SDS-polyacrylamide gel electrophoresis, overlaying the gel with toxin
produced a bound toxin band at the front of the gel where the lipids
migrated. Therefore it is very evident that there is strong experimental




1.3.0 Objectives of the Present Study
The broad abjective at the beginning of this work was to 'study some
aspects of the interaction between gangliosides and protein ligands in
cell membranes'.
The collaboration between Dr. Simon van Heyningen who has many years
experience studying bacterial protein toxins and Dr. Peter Garland who is
interested in biophysical measuring techniques applicable to cell biology,
meant that the expertise for such a study was available.
Dr. Peter Garland was established at Unilever's Colworth Laboratories
where he had set up the instrumentation to carry out Fluorescence Recovery
After Fhotobleaching (FRAP) measurements which define the movement of
ligands and/or receptors on cell membranes. There was also expertise in
Colloidal Gold Electron Microscopy at Colworth.
As cholera toxin was commercially available and is the most understood
bacterial protein toxin, we decided to begin the interaction studies using
this ligand.
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Two lines of study were initiated; one to measure the lateral mobility of
ganglioside GM-j_ (the cell receptor for cholera toxin) in the plasma
membrane and also that of the toxin receptor complex, the second to probe
for possible ganglioside sites intracellularly using the technique of
colloidal gold immunoelectron microscopy, exploiting the strong
specificity of cholera toxin for GM-^ ganglioside.
Technically, both these studies proved to be difficult. The FRAP
measurements depended upon the viability of the cells and how well they
had been labelled with either fluorescent GM^ ganglioside or fluorescent
cholera toxin. The localisation of possible sites intracellularly,
persistently showed intense labelling of cell nuclei, which after many
months and many controls was taken as a valid though currently
unexplainable result (ganglioside GM-^ is not thought to be present
within cell nuclei). Therefore the latter result was pursued using
biochemical techniques to show the existence of a cholera toxin binding
site within a cell nucleus.
Consequently, no direct link was established between the FRAP work and
that of electron microscopy and this thesis presents these two studies as
separate chapters containing their own introduction, specialised technical
details and discussion. Other technical methods which are generally
applicable are described in Chapter two. Chapter five contains a
description of the preliminary binding studies which were initiated from
the electron microscopical determination of a cholera toxin binding site
in the nucleus, which is still uncharacterized. Chapter six provides a




GENERAL MATERIALS AND METHODS
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Chapter 2
GENERAL MATERIALS AND METHODS
SECTION ONE;
2.1.0 General Materials
The reagents used for experiments mentioned in this chapter were obtained
from the following sources:
Cholera toxin Swiss Serum Institute, Berne,
Switzerland
Sigma, Poole, Dorset
(supplied in lyophilised Img
batches)
GM-^ ganglioside Prepared by Mr. N. Gascoyne (see
King et al., 1976) by passing mixed
brain gangliosides down a column of
silica gel Gi to produce pure GM1
(stored lyophilised at 4°C).
Fluorescein thiosemicarbazide Molecular Probes Inc., Junction City,
USA
Radioactive iodide (0.5mCi) Amersham International,
Little Chalfont, England
DE52 Sepharose Pharmacia (Fine Chemicals),
Milton Keynes, England








Miles Scientific, Slough, England




Gift from Dr. R. Holmes
(Holmes and Twiddy, 1983)
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Polyclonal anti-A subunit
(cholera toxin) (B09) and
anti-toxin antisera (A24)
Gift from Dr. R. Holmes
(Holmes and Twiddy, 1983)
HPTLC pre coated silica gel E, Merck, Darmstadt, Germany
60 glass-backed plates (10cm x 10cm)
Sephadex G-25M PD-10 columns Pharmacia (Fine Chemicals),
Milton Keynes, England
Mouse NIH 3T3 fibroblasts Cell line supplied by Unilever
Research Laboratory
Tissue culture medium (EMEM) Flow laboratories, Rickmansworth,
England
Foetal Calf Serum Gibco Ltd., Paisley, Scotland
1 x Trypsin/EDTA solution Gibco Ltd., Paisley, Scotland
The following phosphate buffered saline buffer was routinely used, it is
commonly known as Dulbecces PBS but is referred to as PBS in the text.
The buffer contains (140mM NaCl, 3mM KC1, 8xriM Na2HP04 and 1.5nM KH2
P04) and has a pH of 7.5.
In order to specifically stain gangliosides the Resorcinol reagent was
used. It contains 10ml of 2% aqueous resorcinol solution and 0.25ml of a
0.1M CU2S04 solution together with 80ml of 10M HC1. This is made up
to a total volume of 100ml with distilled water and stored at room
temperature for four hours and then at 4°C for no longer than a month.
All other reagents were analytical grade and were obtained from Sigma or
BDH.
Specialised equipment and materials used for Fluorescence Recovery After
Photobleaching (FRAP) or immunoelectron microscopy are described in





Established cell lines of National Institute of Health (NIH) 3T3 mouse
fibroblasts were maintained in culture flasks (70 cm2) (or on coverslips
6cm x 3cm, in petri dishes) in Dulbecco's Modified Eagles Medium (EXilbecco
and Freeman, 1959) containing 10% foetal calf serum. The medium was
replaced weekly and the cells were trypsinized and 're-seeded'
alternatively to prevent them growing to confluency. Cell density was
calculated using a Coulter counter.
2.2.2 Preparation of Fluorescent Cholera Toxin
Fluorescent toxin (labelled with fluorescein or rhodamine isothio-
cyanate) was prepared following an adapted procedure normally used to
label antibodies fluorescently (Wood et al., 1965; Goding, 1983).
Freeze-dried cholera toxin (1 mg) was dissolved in 1ml of 0.1M bicarbonate
buffer (0.1M sodium carbonate, 0.1M sodium bicarbonate pH 9.5) for several
hours. Then lOOug of a suitable fluorochrome eg. fluorescein
isothiocyanate (diluted in dimethylsulphoxide lOmg/ml) was added for every
mg of cholera toxin and the mixture was incubated in the dark at room
temperature for 2 hr.
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Unconjugated fluorochrome was removed from the conjugated protein by
passing up to 2ml of the mixture down a Sephadex G-25 column (height 5cm,
volume 9ml) which had been previously equilibrated with 0.05M Tris-HCl
buffer (containing 0.2M NaCl and lirM EDTA pH 7.5).
The same buffer was used to elute the column and 500ul or 1ml fractions
were collected into Eppendorf tubes. The absorbance of the fractions at
280nm (protein) and 495/554nm (fluorescent conjugate) was measured on a
Cecil UV spectrophotometer to determine the protein content and the
fluorochrome content (fluorescein 495nm; rhodamine 554nm). (See fig.
2.1) .
2.2.2.1 Calculation of Fluorescein/Protein Ratio
The fractions containing conjugated protein were pooled and the final
absorbance readings taken (see previous section). The molar ratio of
fluorescein to protein in the conjugate was calculated, based on a formula
proposed by The and Feltkamp (1970a,b) for the labelling of immunoglobulin
by FITC. The molar concentrations were calculated using the molar
extinction coefficients for both fluorescein and cholera toxin. As 31% of
the absorbance at 280nm is contributed to by the fluorescein, this is
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A 495 : Absorbance of fluorescein
E 495 : Extinction coefficient (molar) of fluorescein
A 280 : Absorbance of cholera toxin
E 280 : Extinction coefficient (molar) of cholera toxin
E 495 fluorescein = 73 000 1 (Schreiber and Haimovich, 1983)
E 280 cholera toxin = 95 760 M-1cm-1 (LoSpalluto and Firikelstein, 1972)
E 578 rhodamine = 80 000 M-1cm-1 (Hau^iland, 1989)
A ratio of 2 was usually obtained.
Ihe conjugated protein was electrcphoresed on a 12% SDS PAGE gel (see
section 2.3) to check whether both subunits were labelled, see fig. 2.2
It was also checked by the (Xichterlony Technique (see section 2.11) to
if it still bound to GM-j^ ganglioside. It formed a fluorescent
precipitation line with the Gt^.
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FIG 2.1 Elution of Fluorescent Cholera Toxin














MRMk dttNUfe , \
. „*»£ #>-i* c^,.
Fig. 2.2 I Coomassie-stained half of gel showing
molecular weight markers and the two
subunits of cholera toxin.
II UV illuminated other half of above gel
showing that both subunits of cholera
toxin are fluorescently labelled. Four
tracks represent four different
preparations.
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2.2.3 Polvacrvlamide Gel Electrophoresis (PAGE)
Polyacrylarriide gel electrophoresis was always carried out in the presence
of 0.1% w/v SDS (SDS PAGE). The gel and the buffer system was based upon
that of Laemmli (1970) with the addition of 2mM EDTA to chelate metal ions
which may interfere with the polymerisation of acrylamide and cause
aggregation of proteins (Douglas and Butow, 1976). Polyacrylamide of
• f •
molecular weight up to 5 x 10 Da was added to 0.5% (w/v) to increase
the strength of the separating gel. Protein samples (20-100ul) were mixed
with 5ul of 5% 2-mercaptoethanol in water, 5ul of 10% SDS, 5ul of 0.1%
Bromophenol blue containing a drop of glycerol, and incubated in a boiling
water bath for one minute. Samples were then applied to gels and
electrophoresed at 100V for one hour followed by 50-70V overnight.
Gels were fixed in 20% methanol (v/v), 10% acetic acid (v/v) for 15 mins,
stained at 55°C in 55% methanol (v/v), 10% acetic acid (v/v), 0.25%
Coomassie brilliant blue R (w/v) for fifteen minutes, then destained until
the gel background was clear in 5% methanol (v/v), 7.5% acetic acid (v/v),
also at 55°C.
For determination of molecular weights, gels were calibrated with standard
molecular weight marker proteins ranging from 14-200 KDa. The standard
curve shown in fig. 2.3 of electrcphoretic mobility on 12% SDS PAGE
against the log of the molecular weight was obtained. This curve could
then be used for molecular weight determination in the range 10-100 KDa.
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2.2.4 Preparation of Fluorescent GM-^ Ganglioside
A fluorescent <34-^ ganglioside derivative was made according to the
method of Spiegel (1985; 1987).
Freeze dried GM-^ ganglioside (3 mg) was dissolved in 3ml of lOOmM
sodium acetate buffer (pH 5.5) containing 15QmM NaCl and 2mM NaI04 and
left to react for 30 minutes at 0°C. This procedure produces oxidised
GM-^. The reaction was stopped by adding 0.3ml of a 50% aqueous glycerol
solution and the final mixture was dialysed overnight in standard dialysis
tubing with three changes of three litres of water. Then the oxidised and
dialysed GM^ was lyophilised. The oxidised GM-^ was then dissolved in
3ml of PBS and fluorescein thiosemicarazide was added to a concentration
of 5mM. The solution was then incubated overnight at 4°C followed by
dialysis as before this time with four changes of three litres of PBS.
The material was then reduced with lOitiM sodium cyanoborohydride for 15
mins at 23°C followed by dialysis against three changes of three litres
of distilled water and was then analysed by thin layer chromatography
(T.L.C.).
2.2.4.1 Analysis of Fluorescent GMj^ Gamlioside
The fluorescent ganglioside formed a fluorescent 'precipitin line' with
unlabelled cholera toxin using the Ouchterlony technique. Gangliosides are
able to form micelles which might contain both labelled and unlabelled
gangliosides. The binding might therefore represent only binding between
toxin and unlabelled ganglioside. Therefore it was important to determine
the proportion of unlabelled GM^ molecules in the preparation.
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The sialic acid determination assay of Svennerholm (1963) was used to
determine unlabelled ganglioside present in the sample. Hcwever, this
assay yielded no positive results, probably because the sialic acid
residue had been modified by the labelling process and did not react with
resorcinol in this assay. Another method used to determine the amount of
unlabelled ganglioside present was thin layer chromatography (section
2.2.7) and a sensitive overlay technique with radioactive cholera toxin
(section 2.2.8) but both derivatised and underivatised samples
chromatographed with the same run front and could not be separated by
T.L.C.
Samples of unlabelled GM^ ganglioside and derivatised ganglioside were
sent to the Mass Spectroscopy unit at Swansea run by the Science and
Engineering Research Council. They used the technique of fast atom
bombardment mass spectroscopy to determine the molecular weight ions.
They obtained a trace for the unlabelled GM-^ ganglioside with a
molecular weight of 1569Da which is the molecular weight of (3^ plus a
hydrogen ion (see Fig.2.4). The derivatised GM-^ failed to give any
spectra under the conditions they used and they had insufficient material
to try further solvents. Therefore, to date it has not been possible to
characterise fully the derivatised GMj sample and determine the ratio of
unlabelled GM^^ to labelled GM^.
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Figure 2.4 Fast Atom bombardment Mass Spectroscopy trace of GM^
ganglioside indicating molecular ion of mass 1569 daltons, shewing a pure
preparation of the ganglioside
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2.2.5 Preparation of IciG from Rabbit Serum
The polyclonal rabbit serum (van Heyningen, 1976) contained erythrocytes
which obscured initial labelling experiments with colloidal gold, so an
IgG fraction was prepared according to the method of Johnstone (1986).
Serum (50 ml) was warmed to 25°C and 9g of sodium sulphate was added to
make an 18% w/v solution. The mixture was stirred gently and left for 30
min at 25°C. The solution was then centrifuged for 30 min at 3000g at
room temperature, the supernatant discarded and the volume of the pellet
made up to 25ml with distilled water. The solution was again warmed to
25°C and sodium sulphate was added to make a 14% w/v solution, the
solution was left for another 30 min at 25°C. The centrifugation step
was repeated and again the supernatant was discarded. The precipitate was
redissolved in water and made up to a volume of 15ml and dialysed against
three one-litre changes of 0.07M sodium phosphate buffer pH 6.3.
A 1.6cm x 30cm column was filled with DE52 Sepharose and equilibrated with
the sodium phosphate buffer. The 15ml sample was added and 10ml fractions
were collected and their A280 absorbance measured. The fractions
containing protein were redialysed against 0.07M sodium phosphate pH 6.3
and lyophilised.
The lyophilised samples were dissolved in a total volume of 10ml,
reapplied to the DE52 column in sodium phosphate buffer. Four fractions
were eluted containing the protein. These were pooled.
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2.2.6 Preparation of -=^I-labelled Cholera Toxin
Radioactive cholera toxin was made by the chloramine-T method (Greenwood
et al., 1963).
Cholera toxin (20ul of 2mg/ml) was incubated on ice with 50ul of 16mg/ml
chloramine-T solution and 50ul of iodide (0.5 mCi) in lOOmM Tris-HCl 40iriM
NaCl pH 7.5 for 2 min. The reaction was stopped by addition of 50ul of
0.2M sodium iodide and 50ul 2.5mg/ml sodium metabisulphite.
The unconjugated iodide was separated from conjugated protein by passing
200ul aliquots through a 1ml column of Biogel P-6DG in an Eppendorf tube
and centrifuging in an MSE bench centrifuge at 300g for 2 min at roam
temperature.
Then the radioactivity in a lul sample was measured in a gamma counter
(1KB 1282). The stock Img/ml radioactive cholera toxin was stored at 4°
in a lead lined container. To check that both subunits were labelled, the
toxin was run on a SDS PAGE 12% gel and stained to show the protein bands
and dried down in a 1KB slab gel dryer and exposed to Kodak X-ray film at
-70°C overnight. The autoradiograph was then developed and checked
against the gel (see fig. 2.5).
2.2.7 Thin Layer Chromatography
Chromatographs of underivatised and derivatised GM-^ ganglioside (l-5ug)
were routinely run on 10cm x 10cm glass backed silica gel 60 HPTLC plates
in chloroform: methanol: 0.02% (aq) calcium chloride 60:40:10 to about 1cm
from the top of the plate.
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Hie plates were either exposed to iodine vapour which labelled any lipid
or sprayed with the resorcinol reagent and covered and placed at 100°C
for 10 rain which would specifically stain the sialic acid residues.
Different solvents and proportions of solvents were also tried in order to
attempt to resolve underivatised G^ from fluorescein labelled GM-^
(Ledeen and Yu, 1982). The two GT^ samples always had the same mobility
with all conditions tried (see section 2.2.4).
2.2.7.1 Overlay of T.L.C. plates with -^^I-labelled Cholera Toxin
After chromatographs of ganglioside GM^ samples were run as described in
2.2.7. The glass plates were soaked for 1-2 hr in a 1% BSA, 0.2% Tween
solution to block all non specific binding sites. Then the plates were
incubated with 50 mM Tris-HCl buffer (with 150mM NaCl and 1% BSA)
containing the radioactive cholera toxin so that the initial radiaoactive
• ...
measurement of the solution was 10 counts per minute per millilitre of
buffer and this was left in contact with the plates for 30 min. The
plates were then thoroughly washed in three changes of the Tris-HCl buffer
(1 litre) before being dried and autoradiographed.
2.2.8 Indirect Iramunofluorescent Detection of Cholera Toxin Bound
to NTH 3T3 Cells
NIH 3T3 cells were grown normally and seeded out onto glass coverslips at
• f\ • •
a low density of 1 x 10 cells/ml of medium, one day prior to use. The
cells were then fixed in 3% paraformaldehyde in PBS for fifteen minutes at
room temperature. Different coverslips were then incubated with lOOul of
a range of cholera toxin dilutions (10 ug/ml - 30 ug/ml) for 30 min at



















Distance from start of gel
Fig.2.5 Densitometric traces measured on a Joyce Loebl Chromoscan
125
of a 12% gel containing -I-labelled cholera toxin and
the corresponding autoradiograph showing that both A and
B subunits are labelled.
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An incubation with rabbit anti- (cholera toxin) antiserum followed,
dilution being either 1/10 or 1/50 in PBS, for 30 min at room
temperature. This was followed by extensive washing and a final
incubation of the coverslips with FITC-labelled goat anti-(rabbit IgG)
antiserum (1/30 dilution in PBS) for 30 min at room temperature.
The coverslips were then washed again and mounted onto slides and viewed
with a Leitz fluorescence microscope (see fig. 2.6).
The cells were also labelled directly with the fluorescent (FITC labelled)
cholera toxin (see section 2.2.2) at a dilution of 1/100 in PBS.
Labelling of the cells with fluorescent toxin could be prevented by prior
labelling with an excess of unlabelled toxin, demonstrating that a limited
number of binding sites were present per cell.
2.2.9 Titration of NTH 3T3 Cells with Fluorescent Cholera Toxin
NIH 3T3 cells were grown normally and seeded out onto glass coverslips at
a concentration of 60 000 cells/ml.
The fluorescent cholera toxin was serially diluted from (31.25 ug/ml up to
1 mg/ml) in PBS buffer. The cells were incubated with a lOOul aliquot of
the toxin for fifteen minutes at room temperature and then washed several
times in PBS. The coverslips were then mounted onto slides.
The slides were observed by using a Vickers microscope connected to the
laser in the Fluorescence Recovery After Photobleaching (FRAP) set up (see
chapter 3, Fig.3.2). The collimating lens in the laser beam was set to
give a wide illumination of the sample through the microscope objective
and the light intensity from cells and background was measured by the
photomultiplier tube and the voltage reading from this was recorded.
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Fig.2.6 NIH 3T3 cells labelled with 30ug/ml cholera toxin followed by
a 1/10 dilution of anti- (Cholera toxin) antiserum in PBS and a




At least ten individual measurements for each cholera toxin concentration
were recorded and the mean and standard deviation for each was calculated.
The mean voltage values relating to the amount of fluorescence were
plotted against the cholera toxin concentration (see Fig.2.7).
2.2.10 Protein Assay
The Bradford (1976) protein assay was routinely used. A stock solution of
Bradford reagent was made. This contained lOOmg Coomassie blue in 50ml of
95% ethanol and 100ml of phosphoric acid. This was kept at 4°C.
The working solution involved diluting 18ml of the stock reagent up to
100ml with distilled water. To remove aggregates of Coomassie dye, this
solution was filtered through Whatman No. 1 paper before use. Using the
working solution, a standard curve was made with standard BSA solutions
(see fig. 2.8). The assay involved 500ul of test sample and 2.5ml of
working reagent rapidly mixed. The amount of protein in a solution was
related to the absorbance at 595nm read in a Cecil spectrophotometer after
the mixed solution had stood for 30 minutes and was read against a reagent
blank.
2.2.11 Ouchterlony Technique
In order to test that the fluorescent derivatives of cholera toxin and
ganglioside GM-^ bound to underivatised GM-^ and cholera toxin
respectively, the double-diffusion technique was used (Ouchterlony,
1958). Binding was indicated by the formation of a 'precipitin' line
between the two solutions of interest.
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Stock 3% agar was made up in distilled water containing 0.02% sodium azide
and kept in 5ml solidified aliquots. When required, 5ml of 0.1M sodium
phosphate buffer (containing 1.8% sodium chloride) pH 7 was added to a 5ml
agar aliquot.
The mixture was heated in a boiling water bath until the agar had
dissolved. The solution was then allowed to cool to about 60°C and 2ml
of diluted agar was applied pier acid washed slide placed on a black
'level' table. Slides were then placed in a humid box to set. Holes were
cut with an Ouchterlony cutter. Up to 6ul of a cholera toxin/ganglioside
solution was applied to the wells. The slides were then returned to the
humid box overnight after which they were examined for any signs of
binding between the two solutions being tested.
2.2.12 Blotting of Proteins onto Nitrocellulose (Western Blottinch
Gels were electrophoresed as described in section 2.2.3 Prior to
blotting, a nitrocellulose sheet 20cm x 20cm (Anderson and Co. Ltd.)
together with two 'Scotch-Brite' pads were soaked in the transfer buffer
(0.02M Na2HP04; 0.02% SDS (w/v); 20% MeOH (v/v) with some thick filter
pap>er sheets for 2 hours. When the gel had electrophoresed, it was
sandwiched against the nitrocellulose between the filter paper sheets and
the two pads with a clamp. This cassette was then placed in the 1KB
blotter with the nitrocellulose nearer to the anode. Transfer of proteins
was achieved after 2-3 hr with a 10% voltage giving an approximate current
of 0.6 Amps-1.5 Amps.
After the time allotted, the cassette was removed and the nitro-cellulose
either stained to locate the protein bands or placed in blocking buffer
prior to immunostaining (see chapter 5, table 5.0).
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FIG 2.7
Concentration Dependence of Binding of Fluorescent toxin
against NIH 3T3 cells
Cholera toxin concentration (p.g/ml)
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FIG 2.8 standard Curve for Protein assay
by Bradford Method
Concentration of bovine serum albumin (>ig/ml)
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The staining solution consisted of 2g Amido Black 10B (1KB) in 200ml of a
solution of methanol/acetic acid/distilled water 9:2:9; v/v/v. Staining
occurred within ten minutes. Destaining of the background was carried out
in methanol/acetic acid/distilled water; 9:2:9; v/v/v, until clear bands
on a light background were observed (Towbin et al., 1979).
2.2.13 Preparation of Fluorescent BSA in 90% Glycerol
BSA (Img) was dissolved in 5ml of 0.25M phosphate buffer pH 8.0 then 5.8mg
of fluorescein isothiocyanate (FITC) was added and the mixture was
incubated overnight at 4°C.
Pharmacia G-25 columns were equilibrated with PBS and the incubated
mixture was passed through to separate conjugated protein from the
individual components. The FITC-labelled BSA came through in the void
volume.
Finally a known weight of the FITC-BSA solution was mixed with a known
weight of glycerol 90% weight/weight. This mixture was used to calibrate
the laser in the FRAP experiment described in Chapter 3 (Section 3.5.1).
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CHAPTER 3
USE OF FEIJOKESCENCE RECOVERY AFTER racrTrraTFArvTNG TO MEASURE THE IATERAL
DIFFUSION OF CHHTRRA TPYIN AND GM-^ GANGUOSIDE Of NIH 3T3 CET.TS
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CHAPTER 3
USE OF FLOURESCENCE RECOVERY AFTER PHrnYWFACHING TO MEASURE THE LATERAL
DIFFUSION OF CHOTFRA TQXIN AND GANGUOSIDE ON NIH 3T3 CELLS.
3.1.0 Introduction
This chapter describes the measurement of the lateral mobility of inserted
fluorescent GY^ ganglioside into the cell membrane of fibroblasts. The
first measurement of the lateral mobility of fluorescent cholera toxin
bound to fibroblasts, is also described. The lateral mobility measurements
were carried out losing the technique of Fluorescent Recovery after
Photobleaching (FRAP).
The information that can be gained from lateral mobility measurements is
described, showing results obtained by previous workers who examined
fluorescent ganglioside in different systems (cellular and non cellular).
A brief historical review follows on the theoretical development of the
existence of lateral mobility on cell surfaces.
The FRAP technique is described indicating the Important measured
variables which allow calculation of the lateral mobility of fluorescent
cell surface molecules as well as a description of the first experimental
measurement of lateral mobility.
The FRAP equipment is then described followed by the results of the
measurements I made and a discussion of these results.
3.1.1 Why Measure the Lateral Mobility of Cholera Toxin GM-^ Gamlioside
Complexes?
The intermediate steps between cholera toxin binding to its specific
ganglioside receptor and the ensuing activation of adenylate cyclase,
remain unclear.
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The cellular interactions of the ganglioside receptor within the membrane
(its possible attachment to transmembrane components) and how cholera
toxin might alter the receptor to bring about the final effect are
unknown. Therefore the measurement of mobility of in situ cell
ganglioside GM-j^ by use of the fluorescein-labelled cholera toxin in
comparison with that of inserted fluoresceinated GM-^ ganglioside may
provide an opportunity to quantitatively examine the receptor and the
toxin receptor complex in cells. Any differences might give clues as to
(1) How the cholera toxin altered receptor conformation and (2) How the
cholera toxin-GN^ complex may interact with other molecules.
These experiments do assume that inserted ganglioside is in the same
configuration as in situ ganglioside. Inserted ganglioside GM-l has been
widely used in cells lacking the ganglioside to allow binding of cholera
toxin to occur with ensuing activation of adenylate cyclase, (Fishman,
1982).
3.1.2 Previous work on GM-^ Mobility
The mobility of ganglioside GM^ was originally hypothesised after
observations of patching (punctate appearance of receptor once ligand is
bound) and capping (grouping of receptors to one pole of the cell)
following cholera toxin binding in lymphocytes. Table 3.0 summarises
these observations:
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Table 3.0 Table Summarising the Cholera Toxin/Ganglioside Patching





Three-layer immunofluorescence procedure Revesz and
with visualisation using fluorescent rabbit Greaves,
anti-horse serum. 1975
The amount of capping was reduced for a
particular cholera toxin conc. if the number
of GMt molecules was increased.
Cytocnalasin B inhibited capping.
Rat lymph Fluorescein-labelled cholera toxin. Craig and
node cells Inhibition of redistribution by several Cuatre-
metabolic, microtubule and microfilament casas, 1975
inhibitors.
Human Inserted fluorescent-labelled synthetic Sedlacek et
lymphocytes glycolipid (DANSyl-gangliosidoide). al.,
Redistribution is sensitive to colchicine. 1976




Three-layer immunofluorescence procedure Kellie et
with visualisation using fluorescent swine al.,
anti horse serum. Capping is inhibited by 1983
azide, low temperature and cytochalasin B.
Co-capping with a-actinin observed.
Mouse
thymocytes
Inserted fluorescent ganglioside (342. Spiegel et
Co-capping of exogenous GM3 ganglioside al.,
observed. 1984
85
In summary, the experimental evidence indicates that capping of the
cholera toxin receptor complex is an energy dependent process with
involement of the microfilament system, possibly actin. The possible
interaction of GM-^ with the microfilament system must be indirect as the
hydrophobic region of the glycol ipid is not thought to span the bileaflet
membrane. These experiments also indicate that gangliosides may
self-associate in the membrane forming aggregates with themselves or with
other receptors but the physiological explanation for this is not clear.
Previous workers have examined the lateral mobility of inserted
ganglioside and their values for the diffusion coefficient obtained are
summarised in Table 3.1. These measurements were made in order to look at
properties of the plasma membrane. The results shew that inserted
fluorescently labelled GM^ ganglioside has a similar lateral diffusion
coefficient to other membrane inserted lipid probes such as dil
(3.3'-diacylindocarbocyanine iodide) which is similar to a diacyl
phospholipid but the headgroup is more bulky as it contains the
chromophore.
Eldridge et al., (1980) compared the plasma membrane of normal 3T3
fibroblasts with those which had been transformed by SV40 virus. One
method of analysis was to compare the lateral diffusion of a fluorescein
(M-l derivative inserted into the plasma membrane of both types of cell.
He found no difference between the mobility of the ganglioside in normal
and in transformed cells. This experiment could imply that there are no
major cell surface differences or it might indicate that ganglioside
inserts into a similar region in both cell types.
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Schlessinger et al., (1977b) measured the lateral mobility of a
fluorescein ganglioside analogue inserted into chicken embryo fibroblasts
in areas rich or poor in an immobile cell surface glycoprotein to see
whether there was any interaction of the glycolipid with the
glycoprotein. In this system the amount of glycoprotein did not affect
the ganglioside mobility. In this experiment too, ganglioside may insert
itself in distinct regions of the cell surface which are unaffected by the
level of glycoprotein.
Spiegel et al., (1984), measured the lateral mobility of a fluorescent
GM-^ derivative inserted into the cell membrane of a primary culture of
human fibroblasts to show that it was indeed stably inserted (criterion
was to obtain accepted mobility of 10-8cm2s-1 without any immobile
species). She showed that GM-^ mobility depended upon the density of the
fibroblasts. When there was a comparatively high density of fibroblasts
the ganglioside was immobile.
Finally, Goins et al., 1986, examined the mobility of a fluorescent GM-l
ganglioside inserted into artificial lipid membranes
(Dimyristoylphosphatidylcholine (EMPC) vesicles) and examined whether
cholera toxin binding had any effect on the lipid mobility in this
system. He found that cholera toxin binding did not significantly reduce
ganglioside mobility. This experiment may indicate that no major
conformational change occurs in the toxin or that there is no restriction
to diffusion ie no cytoskeletal interactions to bound ganglioside in an
artificial cell membrane system which effect ganglioside mobility within
that membrane.
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3.1.3 The Present Study
As mouse fibroblasts are easy cells to grow, were already established at
c . .
Unilever, and are the cells which have been used most for lateral mobility
measurements, I decided to use them as my model cell.
I re-examined the mobility of ganglioside GM-j^ by inserting the
fluorescent ganglioside into the cell but I was also able to examine the
mobility of endogenous cell-localised GJ^ using fluorescent cholera
toxin, thus also looking at the toxin-receptor complex.
I was able to determine to some extent whether in situ gangliosides and
inserted ganglioside behaved in the same way, and whether toxin binding to
ganglioside in cell membranes rather than liposomes had an effect on
mobility.
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Table 3.1 The Mobility of Fluorescent Lipid probes GM-^ and dil in
Different Cell Systems
PROBE CELL PREPARATION MEAN DIFFUSION REF.
COEFFICIENT
(X 10 Cm S 1)
% MOBILITY












FL-GMj Chicken embryo fibrobast
+immobile glycoprotein 0.42
-immobile glycoprotein 0.46 NOT QUOTED Schlessinger
et al.
1977b
FL-GMj EMPC vesicles 4.7 >80 Goins et al.
1986




diI~Ci8 Mouse 3T3 cell line 86° Wolf et
al.1980
NB All values quoted are the mean experimental values obtained.
The standard error of measurement varied from 15% to 30%.
Measurements were carried out at room temperature (20-22°C).
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3.1.4 Brief Review of the Evidence for Existence of lateral Mobility of
Components on the Cell Surface.
The first definitive experimental demonstration that proteins were able to
diffuse laterally in the cell membrane came from the antigen diffusion
experiment performed by Frye and Edidin (1970). In this well known
experiment, mouse and human cells were fused with Sendai virus to form a
heterokaryon bearing both mouse and human surface antigens, which were
then examined by the indirect fluorescent antibody method. By forty
minutes after fusion, total mixing of both parental antigens had occurred
in over 90% of the heterokaryons. One criticism of this experiment could
be that the virus induced fusion had perturbed the normal topology of the
membrane.
Singer and Nicolson (1972) postulated the fluid mosaic model of cell
membranes. This model required that the membrane was not rigid but in
fact a dynamic structure consisting of protein and lipid in non covalent
associations with one another. Membrane components must be mobile to
serve signal transduction and distribution and redistribution of matter
within the cell and between the cell and its environment. However, there
are specialised areas on plasma membranes such as junctions or pits which
might indicate immobilised membrane components or rigid cell areas or
both. A most striking example of a cell where such specialised areas exist
is an intestinal epithelial cell.
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Another phenomenon on the cell surface which indicates that there is
mobility of components is that of patching and capping first observed by
Moller in 1961 (Moller, 1961). It was not till 1971 that capping was seen
as an indication of lateral mobility of cell surface immunoglobulin (Taylor
et al., 1971). One theory of how capping could occur is postulated by
Bretscher who stated that lipids migrate to the poles of the cell where
they are internalised and in doing so some protein components are also
caught up in the flow; (Bretscher, 1976). However, Bretscher predicts that
• • —10 9 —1 • •
proteins moving as slow as 10 cm s x would cap without antibody
since they could not overcome the flow of membrane lipids, but lateral
• • • —10 9 —1
diffusions of proteins less than 10 cm s have been reported for
uniformly distributed proteins (Edidin, 1981). Patching is independent of
cell metabolism but generally requires a divalent antibody but the
collection of patches into a cap is metabolically driven and much evidence
exists to show that it depends upon the cytoskeleton (Bourguignon and
Singer, 1977, Edidin, 1981). Capping has been observed for cholera toxin
receptors only in lymphocytes (see table 3.0).
Receptors for many regulatory agents, eg. peptide hormones, neuro¬
transmitters and antigens have a dual function of recognising the
appropriate signal and initiating the biological response to its presence.
Originally, it was thought that the receptor and the catalytic domains of
the effector molecules formed a macromolecular complex. However, certain
experimental data do not fit with the hypothesis of the existence of this
complex, especially data concerning those receptors which recognise
hormones activating adenylate cyclase. When two hormones which both
activate adenylate cyclase in the same cell, but bind at different
receptors, are added to that cell together, the maximum level of cAMP
produced is the same as if only one of the hormones had been used.
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This result indicates that the pool of effector molecules is not the same
as that of receptor molecules and that the receptor may migrate once bound
with hormone to the effector, the adenylate cyclase enzyme. Therefore,
the amount of cAMP which may be produced is limited by the number of
catalytic subunits of adenylate cyclase. This idea was postulated by
Jacobs and Cuatrecasas (1977) and is known as 'The Mobile Receptor
Hypothesis'.
This theory eliminates the requirement for single receptor-effector
complexes and allows for the explanation of how a single enzyme e.g.
adenylate cyclase may be regulated by several different receptors and also
the converse idea: how a single receptor can regulate several different
and apparently independent membrane functions. This theory has been
recently discussed by Peters (1988) who confirms that such a model is
still possible despite small measured diffusion coefficients of the
proposed mobile receptor eg b-adrenergic receptor on red blood cell.
Peters presents evidence for cellular subdomains on the cell surface in
the erythrocyte membrane and evidence of the existence of a laterally
mobile signal carrier which could move from the receptor to the effector
molecules within these small subdomains.
Lateral mobility on the cell surface is an accepted phenomenon and has now
been widely studied.
3.2.0 The Fluorescence Recovery After Photobleaching Technique.
Fluorescence microphotolysis, the technique devised by Peters in 1974
(Peters et al., 1974) to measure lateral diffusion of cell surface
molecules on erythrocyte ghosts,
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is also known as Fluorescence Photcfoleaching Recovery (FPR) or
Fluorescence Recovery after Fhotobleaching (FRAP). The latter term will
be used in this description.
The principle of the FRAP technique is simple. Molecules of interest on
the cell's surface are fluorescently labelled and the fluorescence from a
very small region on the surface (usually a circular area 2um in diameter)
is excited by a laser beam which is focused on the small spot through the
objective of a microscope.
Fluorescence is detected with a photomultiplier tube positioned beyond the
image plane of the objective. A pinhole apperture in the image plane is
confocal with the laser spot and reduces stray light and out of phase
fluorescence. To avoid photobleaching at this stage the laser is
attenuated to a few microwatts. Once a steady reading of fluorescence is
achieved a fraction of the fluorophores is irreversibly photochemically
bleached by increasing the laser pcwer incident on the membrane by about
1000 fold for 50-200 milliseconds, after which the laser power is returned
to its original low intensity.
The rate of recovery of fluorescence which results from transport of
unbleached fluorophores into the bleached area from the surrounding area
is measured and from this the diffusion or flow coefficients can be
determined (see fig. 3.1 for a diagrammatic representation of the
bleaching and recovery process and data analysis section for mathematical
interpretation). The fluorophore used is usually fluorescein or rhodamine
and the wavelength for excitation of the fluorophore is chosen such that
it is not absorbed by any components of the cell.
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3.2.1 Theory of FRAP and Data Analysis.
In 1976, Axelrod et al. provided the theoretical basis and simple analysis
of the results derived from FRAP experiments. Fran analysis of the
kinetics, one can differentiate between flew and diffusion, determine the
immobile fraction and measure diffusion coefficients over a wide range
(10-6 to 10-12cm2s-1) over distances of a few microns.
For two dimensional diffusion Einstein states that the mean square
distance x2 moved in a short time, t, is given by:
x2 = 4Dt
or D = x2/4t
where D is the lateral diffusion coefficient.Ihis is similar to the
equation used to determine the lateral diffusion coefficient from FRAP
experiments derived by Axelrod et al, (1976):
°L = w2 y/4T1/2
lateral diffusion coefficient
w = radius of the bleaching area at 1/e2 (0.135) intensity
and the beam has a Guassian profile












y = a constant that depends on the beam profile and the bleaching
parameter K, which in turn depends on the % bleach (which depends on laser
intensity, duration of bleaching pulse, fluorescent extinction coefficient
and the quantum efficiency of bleaching)
The following assumptions were made;
1. Ehotobleaching is a simple, irreversible first order reaction.
2. The amount of fluorescence bleached during the recovery period is
less than 1% of the total fluorescence in the spot.
3. The bleaching time is less than 10% of the characteristic diffusion
time.
4. There is no flow occurring.
The fraction of mobile molecules is given by:
R = Ffoo) - Ffo)
F(-) - F(o)
Where F(-) = fluorescence intensity before bleach
F(o) = fluorescence intensity immediately after the bleach
F(oo) = fluorescence after recovery
R = percentage mobile molecules (percentage recovery)
(see fig. 3.1)
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In 1982, Yguerabide et al. (1982), developed a linear least squares analysis
for even more precise analysis of FRAP data, which was programmed into the
computer for analysis of the traces. Essentially, the Yguerabide analysis fits
the experimental data to a theoretical straight line estimated from the data
and an iterative process occurs until the best fit is obtained between the
experimental and the theoretical data. The residuals presented with the
fitted trace give an idea of the data fit to the straight line. As can be seen
from fig. 3.4 the traces obtained are quite noisy i.e. not smooth lines, but
the program fits a line that approximates well to the data points.
Further information presented on the two traces from the computer analysis
(Fig.3.4) are the percentage recovery i.e. the percentage of mobile molecules,
the T-jy2 value and the % bleach, from which, using a plot of the variation
of the % bleach and y, one can calculate the diffusion coefficient using the
Axelrod equation.
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FLUORESCENCE RECOVERY CURVE INDICATING THE IMPORTANT VARIABLES
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3.2.1.1 Are FRAP Results Radiation-Induced Artefacts?
FRAP has been criticised as a technique to measure cellular diffusion on
cell surfaces as there has been concern regarding possible radiation
damage to the cell and temperature heating effects which it is argued may
alter the diffusion values obtained.
A fundamental calculation by Axelrod (1977) clearly showed that the local
temperature rise in cells is smaller than 0.03°C, even in the worst case
where all absorbed light energy is converted to heat, so local heating
within the cell is unlikely to be significant.
A number of indirect experiments have been carried out which clearly
indicate that FRAP does not produce artefactual results because of cell
damage. The area of membrane where the laser was focused was examined by
scanning electron microscopy and no damage was found. Furthermore cell
impermeability to trypan blue was also checked after FRAP measurements,
also indicating no cell damage had occurred (Jacobson et al, 1978).
Peters and Richter (1981), looked at the effect of FRAP on the
fertilisation and early development of sea urchin eggs and could find no
evidence of radiation damage. In same cases diffusion has been measured
in the same cell by both FRAP and another method and the diffusion
coefficient has been the same. Schlessinger et al. (1977a) measured the
diffusion of a lipid probe in myoblasts by both FRAP and fluorescence
correlation spectroscopy and found no difference in the results.
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Therefore, no evidence at present is available to indicate that the FRAP
procedure produces a significant perturbation of cell structure; low
diffusion coefficient values obtained in cells is probably an indication
of a protein or lipid constrained by interactions with other proteins or
lipids within the membrane or on either side of the membrane (Edidin,
1987).
3.3.0 Initial Measurements of lateral Diffusion of Cell Membrane
Components.
In 1974, two independent groups simultaneously provided the first attempts
at achieving quantitative data for lateral diffusion. Poo and Cone
(1974), measured the diffusion of rhodopsin in rod photo-receptors,
whereas Peters et al. (1974), devised a technique known as 'fluorescence
microphotolysis' to try to measure the mobility of human erythrocyte
membrane components in red blood cell ghosts labelled with the fluorescein
isothiocyanite.
Poo and Cone (1974) found the diffusion coefficient of rhodopsin to be 3.5
_Q p _1 f)
x 10 cm s at 20 C, and they concluded that the membrane of frog
outer segments was highly fluid.
They exploited the intrinsic properties of the rhodopsin chromophore,
which was dark adapted and once bleached could not be regenerated. They
measured the optical absorbance of both sides of a rod by using an
alternator to shift the measuring beam from one side to the other. At the
start of the experiment the absorbance on each side of the rod was
essentially identical.
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After increasing the measuring beam momentarily on one side and then
monitoring absorbance as before, they noticed a decrease in absorbance of
molecules on the side of the rod where they had increased the measuring
beam momentarily. With time, the absorbance readjusted, increasing on the
reduced side and decreasing on the unaltered side of the rod (see
fig.3.2). As glutaraldehyde fixation prevented the readjustment in
absorbance, this experiment clearly indicated that the rhodopsin molecules
were diffusing from one side of the membranes to the other along the
discs.
Poo and Cone also found that the diffusion did not occur lengthwise down
the rod between discs. The diffusion coefficient was calculated using the
distance from one side of the rod to the other and the time taken for
equilibration in absorbance.
The fluorescence microphotolysis method of Peters et al., (1974) which
also measured diffusion did not depend on the membrane having an intrinsic
chromophore. In this experiment, the molecules of interest (the proteins
of the erythrocyte ghost membrane), were fluorescently labelled then only
half a ghost membrane was bleached and measurements were taken to see if
unbleached material would diffuse into the bleached side of the ghost
membrane. It was found that after 20 minutes of measuring, the labelled
molecules appeared immobile within the timescale of the experiment and
from the diffusion equation for a spherical surface Peters derived a
• • • —1 1 9 —1
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Thus, the mobility of proteins on the erythrocyte membrane were found to
be at least 1000 x slower than rhodopsin in frog rod outer segments. The
differences in the two results may be due to;
1) The different lipid compositions of the two membranes (and therefore
different viscosity). Erythrocytes contain more cholesterol and
saturated fatty acids than roost cells.
2) The presence of a cytoskeleton in the erythrocyte (the meshwork of
proteins under the membrane may bind with molecules within the
membrane).
3) The adverse effect on the cells of fluorescent probe addition.
Measurements of lateral diffusion of many proteins and lipids on a variety
of cells and model systems have now been made and have been extensively
reviewed by Peters (1981). These lateral diffusion measurements are
similar to within an order of magnitude whether they have mean measured by
FRAP or other techniques used to measure lateral diffusion such as fusion
or electrophoresis (Cherry, 1979; Peters, 1981).
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THE FRAP METHOD APPARATUS USED
3.4.0 Instrumentation
A diagrammatic representation of the apparatus used to measure lateral
mobility is shown in fig. 3.3
The Laser (Model 85-1, Lexel Corp., Palo Alto, Calif. 94303)
The laser used was a 1 watt (all lines) continuous wave argon ion laser
(with prism line selector). Its most intense wavelength is at 488nm and
the next is at 515.5nm. These wavelengths are the two lines most commonly
used and are suitable for exciting fluorescent dyes such as fluorescein
and rhodamine respectively. The advantages of using laser radiation are
many;
1. The beam is monochromatic.
2. The beam is coherent (in phase).
3. The laser may be tuned to a number of different wavelengths.
4. The intensity of the beam is stronger than other light sources such as
mercury.
5. The beam has a Gaussian transverse energy mode which can be focused to
a diffraction limited spot also of Gaussian energy profile ie there is
a known intensity distribution at the spot.
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Digital Acousto-Optic Modulator (Model 304D, Coherent Associates,
Danbury, Conn. U.S.A)
This device is essential for lateral mobility measurements in the
apparatus available. It allows both a brief intense laser light for the
bleaching phase and a highly attenuated measuring beam for the pre-bleach
and recovery phases. This use was first described by Garland (1981).
Briefly, the apparatus diffracts the laser beam, and the control system
allows it to be on or off. Attenuation of the beam is achieved by
changing the on-off time of the duty cycle. Another important fact is
that the bleaching and measuring modes differ only in the frequency at
which the laser beam is pulsed; and therefore the position of the beam is




The Spatial Filter (Model 1526 Beam Expander with Spatial Filter, Oriel
Scientific, Kingston-upon-Thames, Surrey, U.K.
This equipment consists of a lens and a pinhole and its function is to
attenuate the weaker light intensities not associated with the more
intense Guassian intensity from the laser output. By doing so it also
increases the contrast ratio (ie. the peak to trough intensities of the
modulated beam) approximately 10 fold.
Collimating Lens (80mm Focal Length, from Oriel Scientific)
By adjusting the position of this lens, the size of the laser beam at the
image plane of the objective (and thus at the sample) could be altered.
Thus using a wide beam, the microscope could be used as an ordinary
fluorescence microscope. Photobleaching experiments were carried out with
a small beam.
The Fluorescence Microscope (Model 41, Vickers, Instruments, York, U.K)
This microscope had been adapted for use with the laser by removal of some
of the optics (2 lenses and a diaphragm) to allow laser light to pass in
from the back. The laser beam was passed into the microscope and
reflected down through the objective onto the sample by a dichroic mirror
(Ploem, 1967). Different mirrors may be selected according to the dye
used. Thus, if a fluorescein dye has been used to label the cell surface
molecules, then a green light reflector would be used such that a beam of
45° incident to the mirror would be 95% reflected at 514.5nm and 80%
transmitted above 580nm. Therefore the majority of the laser beam will be
reflected onto the sample and the excited fluorescence will be largely
transmitted.
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The fluorescence then passes thorough a barrier filter, a 3iran thick
non-fluorescent plastic laminate Scholt KV550 filter (H.V. Scan, Solihull,
Birmingham, U.K.). This has 100% transmittance at 600nm, 50% at 550nm and
1% at 535nm which gives seme idea of its cut off characteristics.
The prism normally present in these microscopes to allow visualisation or
photography of the sample was changed so that the laser beam went straight
up instead of back to the camera.
The beam then passes through a pinhole, the size of which depends on the
size of the laser spot being used and its function is to cut out any
background fluorescence. The fluorescence is then detected by a
photQmultiplier tube (EMI model 9813B) with focusing electrode.
The sample is placed on a thermoelectric X-Y stage (Bailey Inst.) and the
incoming beam is focused through a Zeiss X40 water immersion objective.
Optical Components
The whole optical system was arranged on an optical table 1.22 x 0.91m
(Oriel, 1220). Extensive use was made of optical rails (Oriel standard
rails) and adjustable mirror mounts (Oriel model 1450) which were used to
align and direct the laser beam into a 2mm diameter pinhole, the spatial
filter and the collimating lens.
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The Control Electronics
These were designed and constructed by Peter Garland. The instrumentation
consists of;
1. A control for the acousto optic modulator either a) on continuously,
b) pulsed (controlled by frequencies) or c) off.
2. Various measuring frequencies.
3. Control of the length of the bleaching pulse (0.1 - 10 sees).
4. A button to trigger the bleaching pulse.
5. An input signal from the Photo Multiplier Tube. This is a current
signal and it was converted to a voltage with a current-to-voltage
amplifier, followed by a filter of variable time constant (to smooth
out noisy traces on pen recorder).
6. An output signal to the pen recorder (model 28000 from Bryans
Southern Instruments Ltd., Mitcham, Surrey) or to the Gould-4035
digital storage oscilloscope.
Computer
Hewlett-Packard 85 and 9816 microcomputers were used to store the traces
and analyse them by a curve fitting routine based on the Yguerabide (1982)
approximation (programmed by John Birmingham). A television camera (JA1
model 732) was used to observe cells position by transmitted light whilst
setting up each experiment.
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3.5.0 Experimental Procedure
Before each set of measurements was taken under different conditions, a
bleach of fluorescent albumin in 90% glycerol, was carried out to check
the spot size of the laser.
A day before the experiment 0.08-1.2 x 106 cells were seeded onto the
40mm caverslips and left to adhere overnight. All labelling and
washing was performed on the coverslip. For examination by FRAP the
coverslip was inverted onto a slide with a small well containing cell
growth medium (see section 2.2.1). The coverslip was prevented from
•slipping off* by a thin silicon grease seal.
The autofluorescence of unlabelled cells was always measured to check the
viability of the cells (dead cells tended to have high autofluorescence
values). When the slide containing the labelled cells was placed on the
microscope stage, it was left about five minutes for any temperature
equilibration to occur. Before cell signal fluorescence was obtained, a
measure of the background fluorescence was taken. In general, experiments
were only performed if the cell signal to background ratio was at least
10:1.
The TV camera was used to monitor the cells and ensure that the same cell
was not measured more than once. The exact position of the measuring beam
of the laser could also be observed using the video camera.
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3.5.1 Determination of the Spot Size
As can be seen from the equation to calculate the lateral diffusion
coefficient, the spot size of laser must be measured accurately as the
diffusion coefficient depends on the square of its radius (w2). The
easiest method of measuring the spot size, and one that was carried out
before each set of measurements, is that of Thompson and Axelrod (1981).
A simple photableaching recovery experiment was carried out on a standard
sample of fluorescently labelled bovine serum albumin in 90% by wt. of
glycerol (see Materials and Methods). This was sandwiched between a
microscope slide and coverslip into a layer. As the diffusion coefficient
can be calculated theoretically, the spot size can be determined correct
to within 10%. The spot size varied very little over a period of several
months.
Figure 3.4 (overleaf)
Data traces showing the computer analysed 'best fit' for
actual data traces representing:
A) Ganglioside GM-^ (where 80% of the molecules
observed are mobile)
B) Cholera toxin (where only 25% of the molecules
observed are mobile)
• points ~ 380
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3.6.0 Results of Lateral Mobility Measurements
Fig.2.7 in Chapter 2 (section 2.2.9) shews the concentration dependence of
binding of fluorescent toxin against NXH 3T3 fibroblast cells.
Technically this experiment was difficult as the laser spot had to be
increased and thus the whole FRAP equipment needed realignment. The graph
indicates the large variation from two different labelling results. No
steady signal was obtainable at a toxin concentration of less than
lOOug/ml which is approximately a 1 micromolar solution. The for
cholera toxin binding to ganglioside (34-^ is 10-9M so one would expect
saturation at a lum level of toxin. It appears that saturation has not
been reached and this suggests that cholera toxin affinity for GM-j^
ganglioside has been reduced by conjugation with fluorescein.
3.6.1 Measurements with Fluorescent Cholera Toxin
Despite a few initial technical difficulties, setting up the FRAP
equipment and finding the optimal labelling conditions, the FRAP system at
Unilever was used to measure the mobility of fluorescent cholera toxin on
NXH 3T3 fibroblasts very successfully.
The cells were not labelled with cholera toxin for longer than half an
hour, because after this period they tended to become vacuolar either due
to the cholera toxin, or lack of nutrients, even if the cholera toxin was
diluted in serum free medium. labelling time was therefore usually
fifteen minutes at 4°C but coverslips containing labelled cells were
placed on a thermostatically controlled slide while FRAP measurements were
taken. Incubation of the cells with anything less than lOug (lOOul of
lOOug/ml cholera toxin solution) of fluorescently labelled toxin did not
produce a good signal to background ratio,
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and the traces were very noisy because of the large amplification (gain)
needed to observe the signal therefore cells were always labelled with
this amount or greater of fluorescent toxin.
Table 3.II shows the diffusion results obtained with fluorescent cholera
toxin (either labelled with lOOug/ml fluorescein toxin (F-CT) or 500ug/ml
rhodamine labelled toxin (R-CT) as these were the minimum concentrations
required to give good signal to noise ratio). There did not appear to be
any trend in the lateral diffusion coefficient or percentage mobile
fraction of fluorescent molecules (% recovery), if the measurements were
done at the pole or centre of a cell (results not shown). Cholera toxin
diffused on the cells at a rate which varied from about
6xlO-11Gm2s-1 to 6xl0_9cm2s~1 with the mobility varying from
17% to 78%. There was a slight (not significant) increase in both the
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Dl = Lateral diffusion coefficient
% Recovery = percentage of mobile
molecules
Coverslips containing cells (0.08-1.2 xlO ) were labelled with the
specified toxin concentration at 4°C for fifteen minutes. FRAP measurements
were taken after 5 minutes temperature equilibration of the slides containing
coverslips.
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3.6.2 Measurements with Fluorescent GM^ Gamlioside.
Inserted GM-j^ (fluorescently labelled) produced a punctate labelling of
cells (a visual indication of ganglioside clusters). The percentage
recovery obtained varied from about 60%-80% and the lateral diffusion
• —Q ? _1
coefficient was about 1.2 x 10 cms .
A labelling period of half an hour at 37°C was chosen and kept to as
this was a commonly used time period in previous ganglioside mobility
experiments. Further experiments were also performed to examine the effect
of adding unlabelled cholera toxin followed by one or two antibody layers
to cells labelled with inserted fluorescent ganglioside or unlabelled
ganglioside when the second antibody was fluorescently labelled instead.
Addition of cholera toxin (Img/ml) was for 10 min at 4°C. The diffusion
coefficient and percentage recovery of fluorescent ganglioside were not
significantly altered by addition of cholera toxin (about
8.8xl0~10cm2s~1 and 52%-71% respectively). The polyclonal rabbit
anti-cholera toxin was diluted (1/250) in PBS and left on the coverslip
prior to FRAP measurement. Addition of the 1st antibody also had little
affect on the diffusion coefficient and percentage recovery of the
fluorescent ganglioside (2.4xl0-9cm2s-1 and 40-60%). The goat
anti-rabbit antiserum diluted (1/50) in PBS from Miles Scientific was also
left on coverslip prior to FRAP measurement. This second antibody did not
• —10 o —i
seem to alter the diffusion coefficient (7x10 cms ) but the




Diffusion results obtained by labelling mouse 3T3 fibroblasts with exogenous
flourescent GM-l ganglioside alone followed by cholera toxin, rabbit
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F=Fluorescein labelled cholera toxin labelling (Img/ml) for lOmi
1st antibody = rabbit anti-cholera toxin
added 1/250 dilution in PBS
2nd antibody = goat anti-rabbit antibody
added 1/50 dilution in PBS
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3.7.0 Discussion
Both bound cholera toxin and inserted ganglioside lateral diffusion
measurements were obtained. Surface micelles of fluorescent ganglioside
or aggregates of fluorescent cholera toxin can be excluded from the
observations made as such assemblies do not fluoresce (Skiar et al.,
1980).
When cholera toxin bound to NIH 3T3 mouse fibroblasts 17%-78% of the
fluorescent toxin molecules were mobile after binding to the cell surface.
The lateral diffusion coefficient of the cell bound toxin was about 1 x
10-9cm^s~"'-.
Inserted fluorescein-labelled GM^ ganglioside had about 60%-80% mobility
. _Q O __i ,
and a diffusion coefficient 1.2 x 10 cm s x in the same type of
cell.
From these results one can say that addition of cholera toxin to cells
containing inserted GM-^ ganglioside appeared to have no effect on the
mobility of the inserted ganglioside. This observation holds true if one
measures the cholera toxin or the ganglioside mobility. Further addition
of a primary antibody against the cholera toxin did not change these
values of mobility for inserted ganglioside. However addition of a
secondary antibody reduced the fraction of mobile molecules (antibody) to
37%. As the measured species on addition of second antibody was the
second antibody and not the ganglioside, this might indicate that not all
ganglioside species were labelled by the additions and a fuller picture
could have been obtained had it been possible to label both the
ganglioside and the antibodies and follow their mobility concurrently.
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Therefore, the mobility of cell bound cholera toxin appeared to be similar
to the mobility of inserted ganglioside in terms of the percentage of
mobile molecules and the lateral diffusion coefficient. A logical
extension of these observations is that binding of cholera toxin to in
situ cell ganglioside does not appear to alter the number of mobile
ganglioside molecules or the rate at which they diffuse, if one uses
inserted gangliosides as a model for in situ ganglioside mobility.
One might expect a potentially pentavalent molecule such as cholera toxin
to cross link five ganglioside molecules and for this complex to be more
immobile than one ganglioside alone. However, it has been shown by
Saffman and Delbruck (1975) that the size of the macromolecular complex
moving through the viscous lipid membrane has a small effect on mobility
(less than 5% decrease in mobility if size is increased 5 fold). It is
the viscosity of the medium the molecular species is moving through that
has a greater influence on mobility.
Therefore it is not reasonable to assume that a crosslinked
toxin-gangl ioside complex would have a slower lateral diffusion
coefficient than one ganglioside molecule alone unless for some reason one
or more of the gangliosides linked are immobile.
3.7.1 Variation in Results
The standard deviation for the lateral diffusion coefficient values were
high but they were of the same order of magnitude obtained by other
workers working on FRAP measurements of biological specimens (Dragsten et
al., 1979, Foley etal., 1986).
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The variations obtained might have occurred due to effects of the passage
number of the cells measured and therefore their age, the amount of
adherence of individual cells to the glass surface or perhaps the state of
growth of the cell, as these results were obtained for different cells
during an experiment and from different experimental days. Changes in the
mobility of the major histocompatibility antigens were observed in
fibroblasts with increasing age of cell culture, increased cell contact
and with increased extracellular matrix material ( Weir and Edidin,
1986). As a result of this variation only gross differences in the rate
of diffusion or the mobility of the measured ligands can be identified
from such measurements.
Another important factor to consider regarding a possible contribution to
variation in the results obtained is the toxin-ganglioside ratio. The
exact amount of toxin bound to ganglioside for each set of measurements
was not determined but the maximum toxin-ganglioside ratio could be
calculated from the known amount of GM^ molecules on the cell surface (1
• • •
x 10 ) assuming all the toxin available had bound.
This ratio always favoured the toxin, which in all experiments was at
least in twenty fold excess of the total ganglioside present and at most
in one hundred fold excess assuming all the toxin added, bound to the
cell. This high ratio was necessary to obtain sufficient labelling of the
cells to be detected by a photomultiplier tube. This is supporting
evidence together with the binding concentration dependence of fluorescent
toxin, that the binding affinity of the toxin had been lowered when
fluorescein was added. Therefore, the exact stoichiometric ratio of bound
toxin to ganglioside was not known. In experiments with inserted
ganglioside the amount of ganglioside inserted was not determined.
Therefore one can only assume that the data may represent toxin bound to
one or more ganglioside molecules (five being the maximum).
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Perhaps the thirty per cent of immobile toxin molecules represents those
toxin molecules which are bound to GM-^ which is not free to move.
Inserted ganglioside shews a similar degree of immobility, being about
thirty per cent. Maybe thirty percent of the cell surface is immobilised
due to high protein concentrations and/or the presence of cytoskeletal
attachments.
3.7.2 Possible Restraints to GM^/ Cholera Toxin Lateral Diffusion in
the Plasma Membrane.
Although the initial lateral diffusion measurements made were for membrane
proteins, many studies have examined the lateral diffusion of lipids in
cell membranes. The typical diffusion coefficient for a lipid is in the
order of 10-8cm2s-1 (Peters, 1988).
However in artificial membranes, lipids move 10 times faster, indicating
that they are restricted in cellular membranes. This restriction of both
protein and lipid lateral diffusion in cell membranes may indicate
something about their interaction in the membrane. Peters (1981) states
that a simple explanation for the restriction of lipid mobility might be
geometric hindrance by proteins or interactions with lipoproteins.
The data presented in table 3.0 on the capping observed with cholera toxin
receptor complexes suggests that the lateral diffusion of ganglioside
GM-l maybe regulated by transient interactions between transmembrane
integral proteins and cytoskeletal elements.
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Experimental evidence is available to shew that a glycolipid, possibly a
ganglioside is tightly associated with the protein b-j-adrenoreceptor in
turkey erythrocytes (Sinai et al., 1986) and the experimenters state the
generality of this finding. That gangliosides have been found closely
associated with receptors suggests that they may function in
trans-membrane signalling or receptor maintenance and stabilisation within
the bilayer.
In my experiments a population of immobile ganglioside molecules existed
(30% of inserted ganglioside) and this may be because they became
associated with proteins linked to the cytoskeleton or to other in situ
gangliosides which were immobilised by skeletal linkage. This possibility
of ganglioside association is discussed in the following section.
3.7.3 Gamlioside Clusters
The following evidence from lateral diffusion measurements supports the
hypothesis that gangliosides themselves may be clustered. When cells were
labelled with fluorescent gangliosides the labelling appeared punctate
also indicating clustering. The majority of gangliosides are mobile but
some are immobile, and the binding of the cholera toxin might mimic this
distribution. This is not an unreasonable suggestion as the effect of the
crosslinking second antibody could be explained in this context.
The effect of the second antibody would be to cross link cholera toxin
molecules which have at least one immobile ganglioside bound and are thus
immobile with cholera toxin molecules which are bound to up to five mobile
gangliosides.
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This crosslinking would effectively immobilise the whole complex and thus
could account for the 50% reduction in mobile molecules upon addition of
the crosslinking second antibody. Fig. 3.5 indicates three of the
possible binding combinations of cholera toxin with ganglioside, which
cannot be discounted by the data.
Another hypothesis which is not inconsistent with the results is that the
immobile ganglioside clusters may be in distinct regions on the cell
surface. Because, if they were heterogeneously distributed about the cell
surface the data would show a greater fraction of immobile molecules for a
given number of immobile gangliosides.
The idea of gangliosides forming clusters on the cell surface is not a new
one. Spiegel et al. (1984) suggested that gangliosides existed on the
plasma membrane as clusters. She showed that in lymphocytes, addition of
anti-rhodamine antibodies capped both rhodamine and lucifer yellow
labelled gangliosides present in the membrane. Similarly, cholera toxin
capped GM^ and GDla gangliosides, to which it does not bind
indicating that gangliosides may be associated with each other.
Sharom and Grant (1978) using the Electron Proton Resonance (EPR)
spectroscopy technique found that gangliosides exhibited strong
carbohydrate attraction by virtue of the hydrogen bond formation between
carbonyl groups. This fact might explain the immobility of 40% of the
gangliosides. The immobile ganglioside molecules could also be associated
with a protein molecule. These results therefore indicate that the plasma
membrane of fibroblasts is not homogeneous and that distinct regions of
lipids occur within it.
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A) One toxin molecule binding to one mobile ganglioside
B) One toxin molecule binding to more than one mobile ganglioslde
C) One toxin molecule binding to a mixed population of mobile
and Immobile gangllosldes
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In relation to cholera toxin action, it might be the toxin interaction
with the immobile fraction which is important in the further sequence of
events of toxin action i.e. insertion of the active polypeptide.
Furthermore, immobilisation of cell surface constituents by addition of a
cross-linking second antibody has previously been shown in the membrane of
E. coli by Davison and Garland (1983), indicating again regions of mobile
and immobile molecules.
3.7.4 Comparisons of Lateral Diffusion of GM^ Gamlioside with
Previous Measurements
The lateral diffusion coefficient of 1.2 x 10-9cm2s-1 for
fluorescent (34-^ ganglioside compares very well with previously published
results of mobility measurements of ganglioside. It is within one order
of magnitude of the other results.
In these experiments the percentage of mobile ganglioside molecules was
never 100%. However, when Spiegel et al., (1984) performed a similar
experiment in a primary culture of human foreskin fibroblasts, she found
that all the ganglioside molecules were mobile. The difference in
mobility might reflect the difference in density of the cells, as she also
found a correlation between higher cell density and immobility, or it
might just reflect a difference in the organisation of the plasma membrane
of the two fibroblast cell lines. Previous results also indicated a
generally greater mobile fraction of between 90 and 100% for ganglioside
GMj which again might reflect differences in the plasma membrane.
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3.7.4.1 Are Inserted GM-^ Molecules a Good Model for in situ Gamlioside
Molecules?
The evidence that inserted fluorescent GM^ derivatives do function in
the same way as in situ GM-j^ molecules was presented by Spiegel (1985).
She shewed that these inserted derivatives were able to function as
receptors for cholera toxin in cells which had an adenylate cyclase enzyme
but no GM-l molecules. After insertion of the ganglioside the cholera
toxin bound to the cell and activated the adenylate cyclase, which it did
not do on untreated cells. There is much more evidence to suggest that
GM-l molecules act like in situ gangliosides (see section 1.2.4.7).
In principle a better measurement of lateral diffusion of in situ
gangliosides would have been to use a monovalent ligand eg. fluorescent
Fab antibody specifically directed against GM-^. In practice, however,
most antibodies which react with GM-^ will cross-react to some extent
with other glycolipids and glycoproteins and a specific antibody was not
obtainable for these experiments.
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CHAPTER 4
EXAMINATION OF THE rHDTIFRA TOXIN RECEPTOR BY IMMUNOGOID IARRT,T.TNn;
OBSERVATION OF A POSSIBLE NUCLEAR IQCATIQN OF QV^ GANGUQSIDE
IN MOUSE SMAT.T. TNTRSTTNAT. <-FT.T.C!
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CHAPTER 4
EXAMINATION OF THE rHOT.KRA TOXIN RECEPTOR BY IMMUNOGOID TARFT.T.TNr;:
OBSERVATION OF A POSSIBLE NUCLEAR IOCATION OF (3^ GANGIIOSIDE IN MOUSE
SMALL INTESTINAL CRT IS.
4.0 Introduction
In this chapter the first observation of a cholera toxin binding site
(probably ganglioside GM-^) within the heterochromatin of the nucleus of
mouse small intestinal cells is described.
After exploring the mobility of ganglioside GMj on the cell surface by
lateral diffusion I wanted to see whether this receptor could be found
inside a cell and where it was located intracellularly. To answer these
questions the technique of immunogold labelling was used.
To locate the ganglioside GM-^ cholera toxin and an anti-ganglioside
antibody were used as the probes. First a gold-toxin probe was prepared.
Direct observation under the electron microscope was used to check that
toxin was adsorbed to the gold and using an easily grown cell line (NIH 3T3
mouse fibroblasts) it was confirmed that the toxin-probe bound to the cell
surface and was internalised. This test showed that the toxin had retained
its binding properties after combination with the gold. My aim was to use
this toxin-probe on fixed, embedded mouse small intestinal tissue to locate
the intracellular position of the ganglioside GM^ Small intestinal
tissue was chosen because it is the classical target cell of the toxin.
However, the toxin-probe did not bind to the embedded tissue especially on
the plasma membrane, an area known to be rich in ganglioside GM-^.
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The possible reasons for this lack of binding are discussed later.
Therefore, in order to locate the GM-^ in the embedded tissue a sandwich
of probes was used consisting of cholera toxin followed by rabbit
anti-toxin and gold labelled goat-(anti-rabbit) antibody to probe for
intracellular GM-l sites within mouse small intestine.
As background to this chapter a brief historical perspective of the
immunogold technique is given as well as a summary of the properties which
make it a very powerful tool in cell biology. Then the materials and
methods used are detailed, followed by the results obtained. Finally the
results are discussed and related to what is already known about cellular
GM-l ganglioside location and action.
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4.1.0 Background
4.1.1 Historical Perspective -Immunocvtochemistry and Immunoqold
The aim of cytochemical techniques is to localise specific biochemical
components in particular tissue and cell compartments. In 1941, Albert H.
Coons initiated ' immunocytochemistry'. He employed antibodies which were
directed against cell components and were conjugated to a fluorescent
molecule. These were the first experiments to observe the localisation of
cellular components by eye (Coons, 1941). Since then antibodies have also
been conjugated to enzymes (Nakane and Pierce, 1966). The use of an enzyme
allowed visualisation of the antibody location because after a suitable
enzyme-specific substrate had been added, a dense or coloured reaction
product was left.
Essentially two main types of marker exist in cytochemistry. These are
non-particulate or particulate. Horse-radish peroxidase (an enzyme) is an
example of a non-particulate marker. Radioisotopes are also non-particulate
markers. Non-particulate markers are generally sensitive because they can
"amplify" the identification since it is easy to detect their presence.
However precise localisation (especially under the electron microscope) is
made more difficult because of the diffuse signal given (Varndell and
Bolak, 1986). Particulate markers such as ferritin or gold are preferred
for the precise localisation and quantification of cellular components.
This is because one observes their position, rather than their presence.
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4.1.2 Colloidal Gold
Gold particles are negatively charged and they remain stable in solution by
virtue of electrostatic repulsion. However, if electrolytes such as sodium
chloride (Na+Cl~) are added to a colloidal gold solution, the ionic
layers around the gold are compressed and the particles approach one
another.
At a critical distance the particles cohere and flocculation occurs. In
1901, Zsigmondy made the observation that this flocculation of gold was
prevented by addition of protein solutions. This observation is the basis
for the current use of colloidal gold coated to a large variety of
biochemical ligands in immunological studies.
Thiessen (1942) not only proved the particulate nature of colloidal
solutions of gold by electron microscopy but he also observed that proteins
adsorbed to the gold formed layers around the gold particles. Geoghegan and
Ackerman (1977) found that if a protein was added to gold at the pH of its
isoelectric point when the Zwitterion ion form (containing both positive
and negative charges) was predominant, good stable adsorption took place.
This fact is still widely accepted in formation of gold-protein
conjugates. Some recent work however challenges the belief that gold
adsorption must be carried out at the isoelectric point of the protein.
De Roe et al. (1987) discovered that, for some proteins, adsorption of the
protein to the gold was independent of the isoelectric point of the
protein.
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The colloidal gold marker system is now widely used because of the
following advantages:
1) Gold markers are very electron dense and have a characteristic shape,
which means that they are very easily identified and cannot be easily
confused with biological structures.
2) Gold markers are fairly easily prepared, retain most of the binding
properties of the protein/antibody adsorbed and are stable for a long
time.
3) Gold markers may be used both at the light and electron microscope
level.
If a colloidal gold solution consists of spherical particles with a
diameter less than 80 rati, then it is usually a red colour in transmitted
light.
Colloidal gold appears blue if it contains larger particles (> 80m),
aggregated particles or non spherical particles.
It was not until 1971 that colloidal gold was applied in immunological work
with the introduction of 'an immunocolloid method for the electron
microscope' by Faulk and Taylor (1971). In their experiment, rabbit
anti-salmonella antiserum was adsorbed onto gold particles and then
incubated with salmonella bacteria. The surfaces of the bacteria were
specifically labelled. Since this early experiment many other direct
labelling experiments have been carried out.
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Since 1977, very many ultrastructural localisation studies have been
carried out using colloidal gold adsorbed to a variety of ligands such as
immunoglobulins, lectins, toxins and protein A. The following reviews give
a more detailed account of the use of colloidal gold as a marker:
(Horisberger, 1981; Goodman et al., 1981; Roth, 1982, 1983).
4.1.3 Pre-embedding and post-embedding immunoqold
A protein-gold conjugate can be added to a biological preparation before or
after it has been processed and embedded in resin ready for electron
microscopy. Which of these two possibilities is used makes a major
difference to the results and to their interpretation. For a detailed
review of both these methods see the review by Beesley (1985).
Pre-embedding immunolabelling involves detection of the antigen by the
antibody (or receptor by the ligand) immunologically before the tissue is
processed and embedded in resin for electron microscopy. On the other
hand, post-embedding involves immunological detection on sections of tissue
which have already been processed, embedded in resin, sectioned and placed
on grids for electron microscopy.
The pre-embedding technique is usually used for detection of external cell
surface antigens. Post-embedding allows for antigen localisation
internally or externally, but not all antigens survive the tissue fixation
procedures used. The number of antigens exposed to the antibody will also
depend on how the tissue section has been cut.
In my experiment to see whether the gold toxin probe I had made bound to
NIH 3T3 cells I used the pre-embedding technique, whereas in trying to
locate intracellular GM-^ sites I made use of post-embedding immunogold.
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4.2.0 Materials and Methods
Materials
The reagents used for experiments described in this chapter were obtained






2% Solution of dimethyl-
dichlorosilane in 1,1,1
trichloroethane (for




Chadwell Heath, Essex, England
Coverslips (20mm x 20mm)
Slides
Chance Propper Ltd., Sponlane,




Taab Laboratories and Equipment Ltd.,3
Minerva House, Calleva Industrial Park,
Aldermaston, England
Nickel Grids Agar Scientific, 66a Cambridge Road
Stanstead, Essex, England




0.01% Benzoin ethyl ether
Polysciences Inc., 24 low Farm Place,
Moulton Park, Northampton, England
Melanex ICI Chemicals and Polymers Ltd.,
P0 Box 13, The Heath, Runcorn, Cheshire,
England
Collodion Specially prepared at Unilever




Janssen Life Science Products,








Gift from Dr N. Gregson, Dept of Anatomy,
Guys Hospital Medical School, London
B subunit of cholera toxin Separated from whole toxin by gel filtration
on Sephadex G77 column in 5mg/ml 6.5M urea
and 0.IM glycine pH3.2 (T.Scobie Ph.D thesis,
1986)
All other inorganic reagents were analytical grade from BDH and the
biochemicals came from Sigma.
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4.2.1 Methods
4.2.1.1 Preparation of Colloidal Gold
Glassware used in colloidal gold preparation must be scrupulously clean as
contaminants can interfere with formation of the colloid, causing variation
in the particle size. Therefore, after thorough cleaning, glassware must
be rinsed in double distilled, filtered water and then covered in silicon
(Repelcote). All the reagents are also made up in the double-distilled
ultra pure water.
4.2.1.1a The method of Frens (1973)
There are several methods of preparing colloidal gold but this method was
used in preference to the others because it is the only one which produces
gold particles of a uniform size. It was used to produce 16nm diameter
gold particles. The size of the particle produced by this method depends
upon the volume ratio of sodium citrate (1% w/v aqueous solution) to
tetrachloroauric acid (0.001% w/v solution). The greater the volume of
sodium citrate added, the bigger the gold particle is.
One hundred millilitres of a 0.01% (w/v) tetrachloroauric acid solution was
heated to boiling and 4ml of 1% (w/v) trisodium citrate aqueous solution
was then added quickly. After about five minutes of gentle boiling the
colloid was produced and the appearance of a reddish-orange colour
indicated that the reduction was complete.
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4,2.2 Complex Formation of Colloidal Gold with Cholera Toxin
The adsorption of protein onto gold particles is still not a well
understood phenomenon (De Roe et al., 1987; Horisberger, 1981; Goodman et
al., 1981). Roth (1983) states that it is generally assumed that the
proteins adsorb onto the gold surface due to electrostatic interactions
between positive groups on the protein and the negative surface charges on
the gold particles.
Before adsorption, one must first determine the minimum amount of protein
required to stabilise the gold. This is especially important if the
protein is precious! The general method is identical to that followed by
Roth and Binder (1978) who mixed 0.5ml of colloidal gold with 0.1ml of a
serially diluted protein. After about one minute, 0.1ml of 10% aqueous
sodium chloride solution was added and the stabilisation effect was judged
by eye, looking at the colour of the colloidal gold. The lowest protein
concentration which maintained the red colour of the solution after the
NaCl addition was taken as the amount to be used, usually with an extra 10%
added to ensure stability (Geoghegan and Ackerman, 1977).
4.2.2a Formation of Colloidal Gold-Cholera Toxin
The method of Geoghegan and Ackerman, 1977, was followed. Montesano et al.
(1982) had previously made colloidal gold-cholera toxin and had determined
the isoelectric point of cholera toxin as pH 6.9.
Therefore, after 16nm colloidal gold solution had been made by the method
of Frens (1973) (see section 4.2.1.1a), the pH of the solution was adjusted
to 6.9.
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In order to do this a measured aliquot of colloidal gold solution was taken
and a few drops of 1% aqueous polyethylene glycol were added to prevent the
colloidal gold solution from plugging the pores of the pH electrode
(Geoghegan and Ackerman, 1977). Then drops of 0.2M K2CD3 (potassium
carbonate) were added to bring the pH to 6.9. The amounts are then scaled
up for the total volume of colloidal gold solution.
Then 0.5ml of pH-adjusted colloidal gold solution was taken and 0.1ml of a
dilution of cholera toxin (15 ug/ml - 100 ug/ml) was added and the mixture
left for one minute. Then 0.1ml of 10% sodium chloride solution was added
and left for 3 minutes before the solutions were observed by eye and the
absorbance measured at 580nm to check the minimum dilution of protein which
prevented the gold from clumping into large masses. Cholera toxin at a
concentration of 35 ug/ml was the minimum amount required to stabilise the
colloidal gold. See fig. 4.1a, which shows the curve generated from a
series of absorbance readings. The point where the curve becomes asymptotic
with the x axis was taken as the minimum quantity of protein needed to
stabilise the gold. This figure was rounded up to 40 ug/ml just to be
certain that enough protein was present. Thus the minimum protein (cholera
toxin) required per ml of colloidal gold solution was about 8 ug. The
observation that a weight of 4ug (0.1 ml of 40 ug/ml solution) stabilised
0.5 ml gold implies that 8ug will stabilise 1 ml of the colloidal gold
solution.
Therefore at least 800ug of cholera toxin was required to stabilise 100ml
of colloidal gold which had been pH adjusted to 6.9 (isoelectric point of
cholera toxin). The Img batch in which the toxin was supplied was
dissolved in water and added slowly to 100ml of the colloidal gold solution
while it was being gently stirred.
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Seme of this solution was dried onto an electron microscope grid and
lightly counterstained in 2% aqueous uranyl acetate before being observed
by electron microscopy to see if the protein had been successfully adsorbed
onto the gold (see fig. 4.1b). Removal of free uncomplexed protein was
achieved in the follcwing way. The complex was divided into two 50ml
batches and balanced, then given a low speed spin (1500 revolutions per
minute (rpm)) in a Beckman L2-75B ultracentrifuge to remove any gold
aggregates which had formed.
The supernatant was taken and recentrifuged for an hour in the same
centrifuge at 11 500 rpm to separate the colloidal gold-protein from
uncolloided protein. This was repeated to ensure that all the free protein
was removed. Each time the dense red sediment was taken up in PBS/0.2%
Folyetheylene Glycol (PEG). The final volume of concentrated gold-toxin
probe was 10ml.
4.2.3 Storage and Stability of Complexes
The complexes were stored at 4°C with addition of 0.001% sodium azide to
prevent bacterial contamination. It has been shewn that nearly all
proteins so far adsorbed onto gold have maintained their binding or enzymic
properties (Bauer et al., 1975). The exception has been beef liver
catalase, which was completely inactivated by the adsorption process
(Horisberger and Rosset, 1977). Roth (1982) gives evidence for good
stability of most proteins with gold, but states that the complex should be
used within a short time after preparation or centrifuged before use to
remove free protein which might have been released into the buffer.
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Figure 4.1a Shews the curve generated from a series of absorbance
readings of tubes containing 0.5 ml of colloidal gold (with
0.1 ml of a 10 % sodium chloride solution added) against
cholera toxin concentration present in the tubes. The point
where the curve becomes asymptotic to the x axis was taken as













to x axisabsorbance became asymptotic
at this point
Cholera toxin concentration, pg/ml
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4.2.4 Determination of Binding Properties of Colloidal Gold - Toxin Probe
4.2.4.1 Experimental Procedure
NIH 3T3 cells were plated on plastic (ICI Melanex) coverslips, one day
prior to use. Some cells were then labelled at 37°C with 1ml of
colloidal gold-cholera toxin conjugate at 1/50 dilution in PBS. Other cells
were labelled with the same concentration of gold conjugate after fixation
in 2% glutaraldehyde/0.5% paraformaldehyde in PBS pH 7.5. After 30 min
incubation all cells were further fixed for fifteen minutes in the same
fixative. Additional coverslips acted as controls where an excess of
unlabelled toxin was added to the cells (1 ml of 1 mg/ml toxin) before
fixation and addition of gold labelled toxin. The coverslips were then
dehydrated through a series of increasing alcohol concentrations (50% to
100%) and placed longitudinally in a gelatin capsule where they were left
overnight in a resin mix (4 volumes LR gold to 1 volume GMA containing
0.01% benzoin ethyl ether). The resin was renewed and polymerised at room
temperature for 24 hrs under a U.V. light. The resin blocks were prepared
for cutting with a glass knife; then thin sections (80-100nm) were cut with
an ultramicrotcme (Sorvall MT-2) using a diamond knife (Dupont Ltd.), and
mounted on nickel grids. The cell sections were examined with a Jeol 10OCX
2 electron microscope with an accelerating voltage of 80KV.
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An adult F-^ C57B x CBA mouse was sacrificed by cervical dislocation and
the small intestine removed. The tissue was then fixed in freshly prepared
1% paraformaldehyde/0.5% gluteraldehyde in PBS for 2 hours at 4°C. As
much of the gut contents were removed as possible by forcing them out with
a 'jet' of PBS. The tissue was then cut into small transverse sections and
these were dehydrated through graded alcohols (fifteen minutes in 50%
through to absolute alcohol). The tissue was then embedded in hydrophilic
resin block (3 parts LR gold, 2 parts glycol methacrylate (GMA) low acid
0.01% benzoin ethyl ether). The blocks were polymerised for 24 hr at room
temperature by U.V. irradiation. Sections were cut using a Sorvall MT-2
ultramicrotome with a diamond knife (Dupont Ltd.) and mounted onto nickel
grids.
4.2.5.1.2 Tmmunolabellim Procedure
All incubations were done in a moist chamber. Collodion-coated nickel
grids with the attached thin sections were placed on a droplet of 0.5M
ammonium chloride at room temperature for one hour. This is important to
block any free aldehyde groups exposed from the fixation which are reactive
with e-amino groups on proteins. Then the grids were washed with a spray
of PBS and placed on a 1% - 3% ovalbumin solution in PBS for 30 mins at
37°C as a further blocking procedure.
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Grids were then transferred onto lOul diluted drops of colloidal gold
toxin conjugate (1/50 to 1/500) or lOul drops of 850ng/ml cholera toxin
diluted in the ovalbumin solution and incubated for 30 min at 37°C. The
cholera toxin dilution (850ng/ml) was that used by Hansson et al., (1977)
which also gave intense specific labelling and a low background. The
antibody concentrations were chosen in the same manner.
The grids were then 'jet' washed gently with PBS sprayed from a Pasteur
pipette several times. After washing, the grids were placed section down
on a lOul drop of 1/250 rabbit anti- (cholera toxin) serum diluted in PBS
and incubated for one hour at 37°C. At this stage in some experiments,
grids were labelled with a 1/50 dilution of anti-GT^ antibody.
Experiments were also carried out using both antisera to examine whether
one would block the other. The washing procedure was repeated and the
grids were then incubated with gold labelled goat anti-(rabbit IgG)
antiserum at 1/50 dilution in PBS for 30 min at 37°C.
The grids were again washed in PBS as before and further washed in
distilled water. Counterstaining of the sections was carried out for 5 min
in 2% aqueous uranyl acetate followed by 1 min in lead citrate at roam
temperature.
The next page illustrates the binding steps in a flew chart.
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FLOW CHART SHOWING THE DIFFERENT BINDING STEPS USED TO IDENTIFY PHOT IRPA
TOXIN RECEPTORS IN ■CIMAT ,T, MOTTSE INTESTINE
Thin section on collodion coated nickel grid
Placed on 0.5M Ammonium Chloride aqueous solution
22°C for one hour then washed in PBS
Placed on 1-3% Ovalbumin in PBS solution
37°C for 30 minutes
Placed on 10 ul drop of 850 ng/ml cholera toxin diluted in 1-3% ovalbumin
diluted in PBS
37°C for 30 minutes then washed in PBS
Placed on 10 ul drop of 1/250 PBS diluted rabbit anti-cholera toxin IgG
37° C for one hour then washed in PBS
Placed on 10 ul drop of 1/50 PBS diluted gold labelled goat anti-rabbit
antibody at 37° C for 30 minutes then washed with PBS and water
followed by staining for electron microscopy
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Many control binding experiments were also performed to indicate the
specificity of the reagents used. The following table summarises these
controls and what they would shew if binding was observed;
CONTROL PERFORMED COMMENTS
Cholera toxin step was emitted.
The cholera toxin (850 ng/ml)
was incubated with excess GM^.
(1 mg/ml).
The rabbit antiserum 1/250 PBS
dilution was preabsorbed with an
equal volume of 850 ng/ml cholera
toxin.
The rabbit anti-toxin antibody
was omitted.
Both cholera toxin and rabbit
antibody step were emitted.
This experiment indicates any
non-specific binding of the rabbit
anti-cholera toxin antibody.
This experiment shows any impurity
present in cholera toxin preparation,
which might bind to section.
This experiment also shows any
non-specific binding of the rabbit
anti-toxin antibody.
This experiment shows non specific
binding of the goat anti-rabbit
antibody to toxin or section.
This experiment also shows non specific
binding of the second antibody to the
section.
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Fig.4.lb Colloidal gold-cholera toxin (15nm) shewing the 'halo' of
protein (cholera toxin) adsorbed to it. The gold-cholera
toxin probe was made according to the method of Geoghegan and
Ackerman, (1977) and dried onto a collodion coated nickel
grid before counterstaining lightly with 2% uranyl acetate.
Bar indicates lum
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The B subunit alone was used
for binding (lug/ml).
This experiment confirms that the toxin
is binding to (341 ganglioside
receptor.
4.3.0 Results
4.3.1 Binding Properties of Colloidal Gold-Toxin Probe
4.3.1.1 Examination by electron microscopy
Cholera toxin was successfully adsorbed onto the cholera toxin colloidal
gold. Fig 4.2 shows a non electron dense halo surrounding the 15nm gold
particles which is a layer of cholera toxin molecules adsorbed onto the
gold.
4.3.1.2 Results and Discussion
The colloidal gold-toxin probe bound specifically to the plasma membrane of
NIH 3T3 cells.
Figs.4.2a and b show the typical labelling pattern obtained on cells fixed
and then labelled at room temperature. The labelling occurs along the
plasma membrane. This labelling is specific as an excess of unlabelled
toxin prevents labelling. Figs.4.2c and d show NIH 3T3 cells labelled at
37°C prior to fixation. Cells labelled with the probe at this temperature
internalise it into vesicles near the cell surface during the time course
of 30 min before fixation.
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Control cells labelled with an excess of unlabelled cholera toxin before
fixation prior to labelling with the gold toxin probe are not shown as they
showed no labelling with colloidal gold toxin.
The labelling on the cells fixed and then labelled at room temperature was
all on the plasma membrane with no observable internalisation of the
label. Because the control cells showed no labelling this indicates that
the toxin adsorbed to gold binds to the same sites as unlabelled toxin. At
37°C the colloidal gold-cholera toxin conjugate appeared to have labelled
the cell surface more heavily and become associated with non-coated cell
surface invaginations. Gold particles were also located in vesicular
structures within the cytoplasm near the cell surface.
Internalisation of colloidal gold-cholera toxin conjugates has previously
been commented upon by Montesano et al. (1982), in cultured liver cells.
This experiment indicated that both cholera toxin and tetanus toxin gold
conjugates bound specifically and entered the liver cells by flask-shaped
non-coated invaginations. It was suggested that these invaginations might
be a route specific for glycolipid internalisation. I essentially repeated
this experiment with NTH 3T3 cells, using it to check that the cholera
toxin retained its binding properties once adsorbed to gold and to see
whether I could repeat the observations in a different cell line .
The cholera toxin conjugate in ray experiment was generally not associated
with coated pit structures but with smaller uncoated vesicles. This result
is similar to that obtained by Montesano et al. (1982). These vesicles have
been described by Rohlich and Allison (1976) who stated that they were only
observed in some areas of the membrane and that they had a longitudinal row
pattern which was partially disrupted by Cytochalasin B, indicating the
involvement of microfilaments in this arrangement.
148
It is possible that such uncoated vesicles participate in endocytosis of
macrcaDolecules from the cell surface. The 'longitudinal row' pattern of
these vesicles was not visible in the sections examined, but this may be
due to angles of cutting sections failing to reveal inner vesicles.
Hie internalisation of the toxin-gold complex via these uncoated vesicles
must be a fairly slow process in NIH 3T3 fibroblasts as the much of the
complex was still present on the cell surface. Joseph et al. (1979) found
that peroxidase labelled cholera toxin was taken up and reached the golgi
of murine neuroblastoma cells within thirty minutes. Using rat liver and
125I-labelled toxin, Janicot and Desbuquois (1987) showed that the whole
toxin was taken up after fifteen minutes and was associated with endosomes,
lysosomes and the golgi during this time. All these experiments confirm
that the GM-^ receptor is probably recycled but it is not clear whether
this process requires the presence of the toxin as in all cases it is
presumed that the toxin was bound to the receptor during internalisation
These experiments therefore indicate that there is a mechanism for uptake
of whole toxin in cells which bind the toxin at their surface. NIH 3T3
cells and liver cells both bound the gold toxin probe specifically at their
surface and were able to internalise this probe. The experiments also show
that the GM^ receptor may be internalised into the cell with cholera
toxin bound to it. Internalisation was observed by virtue of the bound
toxin probe.
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Figs.4.2a,b NIH 3T3 cells incubated with colloidal-gold cholera
toxin at room temperature for 30 min. Note that the










incubated with colloidal gold cholera
for 30 min. Gold particles are found
invaginations on the plasma membrane and
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4.3.2 Localisation of Cholera Toxin Binding Sites on Sections of Mouse
Small Intestine
4.3.2.1 Binding of the colloidal gold-toxin probe to mouse small
intestine
None of the dilutions of colloidal gold toxin probe that were tested
(1/50 to 1/500) bound to the sections of mouse small intestine. One
explanation for this observation might be that the gold conjugate was too
large and sterically hindered its own binding because of the proximity of
the binding sites on the tissue section. This hypothesis could have been
verified by preparing additional gold toxin probes with gold of varying
diameters but there was insufficient time to prepare several batches of
different sized gold and the cost of toxin prohibited this analysis.
Another reason might have been that the protein was no longer attached to
the gold or had reduced binding properties. These reasons also could have
been tested by repeating the NIH 3T3 binding experiment, but loss of
protein was thought to be unlikely. The most plausible reason may have
been due to reduced hydrophilicity of the resin (personal communication
Dr Arthur Rowe, Dept. of Biochemistry, University of Leceister). I
decided therefore to try and label the mouse small intestinal sections
with toxin itself followed by a sandwich of antibodies. This approach did
produce labelling and indicates possibly that the toxin probe could not
bind strongly enough to the resin due to its lack of hydrophilicity
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4.3.2.2 Results of binding using cholera toxin followed by antibodies
The results presented in this section have been reproduced at least 10
times on both mouse and rat tissue.
Cholera toxin bound sparsely to the microvilli, to sites within vesicular
structures in the cytoplasm and, most surprisingly, both whole toxin and
B subunit alone bound to the heterochromatin of the nuclei (see fig.4.3b
and c). This binding was specific, as all the controls (except one) to
test specificity of the reagents produced no gold labelling on the
section.
CONTROL PERFORMED COMMENTS
Cholera toxin step was omitted. Some binding was observed only to
organism outside intestinal tissue.
No binding on intestinal tissue. See
fig. 4.3e.
The cholera toxin (850 ng/ml
incubated with excess GM^^
(1 mg/ml).
was No binding was observed
The rabbit antiserum 1/250 PBS
dilution was preabsorbed with an
equal volume of 850 ng/ml cholera
toxin.




The rabbit anti-toxin antibody No binding was observed. See fig 4.3d.
was emitted.
Both cholera toxin and rabbit No binding was observed
antibody step were emitted.
On the labelled control the gold particles were observed on an organism
attached to the microvilli.
It was presumed that this organism was the E.coli strain which produces a
toxin very homologous to cholera toxin. The gold particles were only
observed around the organism and not on the gut tissue itself (see
fig.4.3e).
Anti-GM-^ antibody also bound both to the nucleus and the microvilli
(see fig.4.3a) indicating the presence of GM-^ by an independent
ligand. Some of these sites might not be ganglioside GM-^ as this
antiserum did show some cross reactivity with asialo ganglioside GM^^
and some reactivity with ganglioside GD-^ (personal communication from
Dr.N.Gregson). This binding pattern was also observed in rat intestine.
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Fig.4.3a Shews the binding of anti ganglioside GM^ antibody (1/50
dilution in PBS) to a section of mouse intestine
Fig.4.3b Shews the novel heterochrcmatin binding site of the B subunit




Fig.4.3c Binding of whole cholera toxin (850ng/ml) to a section of
intestine




Fig.4.3e Control (cholera toxin emitted) indicating the binding of the
primary antibody to a gut organism, probably E.coli.
Fig.4.3f Control: pre-incubation of cholera toxin with primary
antiserum (850ng/ml Cholera toxin + 1/250 dilution primary





In this experiment I decided to exploit the high binding affinity of
cholera toxin for GM-|_ ganglioside and the sensitive post-embedding
immunogold localisation technique to probe for extracellular and
intracellular cholera toxin binding sites which I presumed would represent
the (3^ distribution of the cell. I used mouse small intestinal tissue
as this is a target tissue for cholera toxin.
In previous immunocytochemical experiments to locate GM^ ganglioside on
cell surfaces, cholera toxin was the GMj probe because of its known
specificity for the molecule.
One of the early ganglioside localisation experiments using the
electron microscope was performed by Hansson in 1977. The cells Hansson
examined were incubated with cholera toxin at room temperature (18°C+/~
1) and then rinsed. Following this, the cells were immersed in peroxidase
conjugated anti-cholera toxin immunoglobulin for 30 mins and then fixed and
further stained. A large number of cells (200-1000) were examined.
Binding was also carried out at 4°C and 37°C and controls were studied
too where the toxin had been omitted before tissue processing or with
omission of the antibody step. Hansson showed that binding occurred
predominantly on the plasma membranes and his results correlated well with
previous workers who had estimated the levels of GMn on different cell
membranes. Hansson also examined the binding of cholera toxin on the
clinical target - human small intestine. He observed that the microvilli
showed patchy labelling. There was a smaller amount of precipitate on
lateral and basal membranes. A prominent binding region was the caveolar
membranes and the junctional complexes between adjacent epithelial cells
(Hansson et al., 1977).
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The colloidal gold technique has also been applied to the localisation of
GM-l on human blood cells and bone marrow (Ackerman et al., 1980). In
these experiments IgG-F(ab')2 anti-cholera toxin was used to prevent non¬
specific activity with Fc receptor sites on monocytes. The Fab fragments
were adsorbed to the colloidal gold and used to localise cholera toxin
which had previously been incubated with cells or marrow.
Binding of cholera toxin to intestinal cells to locate intracellular GM-j_
sites by post-embedding immunogold has been examined once previously. In
this case gold-toxin probe was used which bound to the cell specifically
(excess unlabelled toxin prevented its binding). Labelling was found on the
plasma membrane and intracellularly in vesicles in addition to the golgi
apparatus but there is no mention of any nuclear binding. The main
differences between this experiment and my own was the use of human rather
than mouse intestinal tissue and the use of different fixative and
embedding procedures to process the tissue (Roth, 1985). The difference in
results may well therefore reflect a difference in intracellular
gangliosides between mice and human tissue or provide evidence that some
fixation/embedding procedures may abolish or prevent detection of some
cellular components.
In addition to locating GM^ externally and internally on cells by
immunocytochemical means, workers have also tried to locate the molecule
intracellularly by biochemical fractionation techniques (Keenan et al.,
1972 a, b). These experiments indicated that perhaps only a small number
of gangliosides were located on the plasma membrane compared to the total
cell content of gangliosides.
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4.4.1 Are the binding sites GMj?
The results presented shew potential binding sites for cholera toxin
associated with heterochromatin in the nucleus. It seems likely that these
sites are ganglioside the only receptor for the toxin that has been
positively identified. This conclusion is supported by the observation
that preincubation of the toxin with ganglioside GM-^ inhibits the
binding, presumably because the binding site (on the toxin molecule) is no
longer available (although conceivably because of transmitted
conformational change to a different binding site). Further support comes
from the fact that anti GM-l antibody binds to sites parallel to those of
toxin in the same tissue. It is true that GM-^ antibody binding did not
interfere with that of toxin but this could be explained if, as is
probable, the affinity of the antibody for GM-l is lower than that of
toxin, or if anti-GM1 antibody does not bind to all possible sites.
From previous cell fractionation experiments, it is known that ganglioside
in mammary and liver tissue is mainly associated with plasma membranes, but
some was found in other cellular membranes and it was not a result of cross
contamination from the plasma membrane (Keenan et al., 1972 a, b).
However, the heterochromatin localisation of ganglioside has never been
suggested. Current evidence suggests that ganglioside synthesis begins in
endoplasmic reticulum, then there is transport to the golgi and termination
at the plasma membrane (Keenan et al., 1974; Lipsky and Pagano, 1985). At
no stage is the nucleus thought to be involved. It is possible that a
conformational epitope is being recognised in the nucleus by the antibody
and not an actual glycolipid. Ibis phenomenon has already been reported by
Freddo et al. (1986) who showed that a monoclonal anti-DNA antibody bound
to a conformational epitope formed by phosphatidic acid and gangliosides.
165
Interferons which bind to a ganglioside receptor and modulate growth (like
the B subunit of cholera toxin) (Spiegel, 1988) have intranuclear binding
sites (Burwen and Jones, 1987).
The question of intranuclear receptors for growth factors and polypeptide
hormones was critically discussed by Evans and Bergeron (1988) who argue
that the evidence for such intranuclear sites is equivocal (further
discussed in Chapter 5).
It is also possible that the binding site observed could be a glycoprotein
with a similar structure. Cell surface glycoproteins having irnrtiunochemical
properties similar to GM-^ ganglioside have been identified in fibroblasts
(Tonegawa and Hakamori, 1977). Additionally nucleoplasmic glycoproteins
are known to exist (Hart et al, 1988).
Despite the lack of additional data to support ganglioside GM^
localisation in the nucleus, it still remains true that cholera toxin is
probably the most sensitive available probe for GM-^.
4.4.2 Relevance of a possible GM-^ binding site
These binding results do not imply that the nuclear binding sites can be
reached by the toxin when it is working in the intact cell or in vivo, nor
do they in themselves suggest any physiological role for binding in the
nucleus. However these results do beg the question "What is the role of
ganglioside GM1 in the heterochromatin of the nucleus?"
Experiments on internalisation of peroxidase-conjugated or 125i- labelled
toxin into intact cells have shown the toxin to be associated with a number
of intracellular organelles eg. the golgi complex (Joseph et al., 1979).
There has been no evidence for any particular binding to the nucleus.
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There is evidence, however, that gangliosides are associated with cell
growth and differentiation and so perhaps with gene expression in the
nucleus.
Altered ganglioside metabolism and organisation have been related to
oncogenic transformation, cell cycle and density dependent growth
inhibition (Fishman and Brady 1976; Hakamori,1981; Feizi, 1985).
Several studies have also indicated that the cresslinking (by antibody or
pentavalent cholera toxin) of cell surface gangliosides either endogenously
derived or exogenously supplied, can regulate DNA synthesis (Spiegel and
Fishman, 1987). Polyanionic micelles of GM^ ganglioside have also been
shown to inhibit DNA synthesis in isolated nuclei by affecting the activity
of ENA polymerase alpha fractionated from S-Fhase Hela cells (Ohsawa et
al., 1988).
Therefore there is implication of ganglioside involvement at a nuclear
level but no direct proof exists yet.
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CHAFFER 5




BIOCHEMICAL EVIDENCE FOR A CHOLERA TOXIN BINDING SITE IN INTESTINAL CELL
NUCLEI
5.1.0 INTRODUCTION
The work described in Chapter 4, using the technique of imraunogold
electron microscopy, indicated the existence of a novel binding site for
cholera toxin in mouse intestinal cells. The toxin was shown to bind to
the dense chromatin, primarily located near the nuclear membrane of mouse
small intestinal cells.
This specific binding of cholera toxin is intriguing, as it points to the
presence of a GM^like molecule within the nucleus. The binding site
might be physiologically relevant to the action of cholera toxin.
Preparation of the tissue for examination by electron microscopy involves
many chemical reagents which might have produced an artificial binding
site although the controls performed do indicate the presence of a GMj
ganglioside-like molecule. It was decided therefore, to attempt to
demonstrate this toxin binding site by biochemical methods. The site was
probed for by Western blotting of nuclear membrane fractions which would
still have associated chromatin, but this yielded no evidence of binding.
Simple direct binding experiments were also performed with radioiodinated
cholera toxin. These latter experiments did indicate the presence of a
specific binding site.
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5.2.0 Preparation of Nuclear Envelope Membranes from Rabbit Intestinal
Cells
5.2.1 Isolation of Intestinal Epithelial Cell Nuclei
An adult New Zealand white rabbit was sacrificed by cervical dislocation
and its small intestine removed and placed in a 0.9% w/v sodium chloride
solution (saline).
The gut contents were forced out, by washing through with the saline
solution. The gut was then cut into 10cm lengths, and these tubes were
cut along the mesenteric border. The mucosal cells were scraped gently
using a glass slide and placed in 50mM mannitol buffer containing 4mM
magnesium chloride and 5mM Hepes buffer pH 7.5. The cells were
homogenized in a Jencons Potter-Elvehjem homogeniser. The mixture was
then centrifuged at 800g for 10 min (4°C) in a Beckman J2-21 centrifuge
in a Ja-14 rotor, to remove cell debris. The supernatant was removed and
the pellet was resuspended in the same buffer. The resuspended mixture
was centrifuged at lOOOg for 10 min (4°C) in the same rotor to pellet
the nuclei.
The pellet was taken up in 70% sucrose solution to make an effective
sucrose solution of just under 56%. This was then layered onto 56%
sucrose and spun at 60 OOOg for an hour at 4°C in a 50Ti rotor in a
Beckman L8-55 ultracentrifuge. This process separates nuclei from
contaminating small cell debris. Finally, the pellet was washed with the
50mM mannitol buffer to remove the sucrose (Bloebel and Potter, 1966).
This preparation of nuclei was then further processed.
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5.2.2 Nuclear Membrane Preparation
Dr. Paul Agutter from Napier College, Edinburgh has been studying the
nuclear membranes for several years and has written several books on the
subject (Agutter, 1986).
He is therefore experienced in the preparation of nuclear envelope
membranes and associated chromatin. He advised me to use the following
adapted technique of Harris and Milne (1974) to prepare the nuclear
envelope membranes with associated heterochrcmatin.
The nuclei were resuspended in a liriM NaHC03 solution (pH 7.2-8.0) until
the absorbance of the solution at 400nm read between 0.1-0.2 units of
absorbance (method communicated by Dr. Agutter to give a suitable dilution
of nuclei).
The mixture was equilibrated for five minutes before centrifugation at 20
OOOg for 10 minutes at 4°C in a JA-20 rotor in a Beekman J2-21
centrifuge. The pellet was resuspended in the bicarbonate solution which
had been warmed to 25°C and the mixture was left for fifteen minutes.
Then DNAase 1 was added to a concentration of lOug/ml. The solution was
centrifuged again as before at 20 OOOg and again the pellet was
resuspended.
A cycle of resuspension and centrifugations followed until the A 260nm
absorbance reading (absorbance of nucleic acid) was reduced to less than
0.5 units of absorbance. The A 260nm readings gave an indication of the
amount of DMA still in the preparation.
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Hie final preparation of nuclear envelope and associated chromatin was run
on a 12% SDS PAGE gel (see section 2.2.5 and fig 5.0) and compared with
published preparations (Kaufmann et al., 1983), which were found to be
similar.
In addition, because there were no antibodies available to verify the
presence of nuclear membrane proteins, the SDS PAGE gels were examined by
Dr. Agutter who confirmed the protein pattern to be characteristic of
nuclear membrane and associated proteins (personal communication Dr. P.S.
Agutter).
This preparation was stored at -20°C in 1ml aliquots with protein
concentrations of 0.06mg/ml and 2mg/ml.
5.3.0 Immunoblottincr of Nuclear Envelope Preparations Transferred onto
Nitrocellulose
Nuclear envelope preparations were loaded onto 12% SDS PAGE gels (about
70mg protein) and electrophoresed and then transferred onto nitrocellulose
as described in section 2.2.12.
Two of the tracks of the nitrocellulose containing molecular weight
markers and nuclear envelope and associated proteins respectively were
stained with Amido Black (see section 2.2.12). The other half of the
nitrocellulose was soaked in a solution of 1% BSA and 2% Tween overnight
to block non-specific protein binding sites on the nitrocellulose. The
blot was then cut into strips representing individual tracks of protein.




Cholera toxin failed to bind to any component of the nuclear envelope
preparations after the proteins had been separated by SDS PAGE on a 12%
gel and blotted onto nitrocellulose.
In order to test the procedure a positive control was carried out.
Cholera toxin (50ug) was run on a 12% SDS PAGE gel and blotted onto
nitrocellulose.
There was apparent binding at lOOug/ml of cholera toxin but this was shown
to be non-specific. Strips incubated with cholera toxin at concentrations
of 10 and 50ug/ml did not indicate any binding.
This was then immunostained with a 1/250 dilution in PBS of the primary
antibody and a 1/100 dilution also in PBS of the peroxidase conjugated
second antibody obtained from the Scottish Antibody Production Unit
(SARJ). The B subunit of cholera toxin showed staining using this
procedure, indicating that the experimental protocol was working.
The possible reasons for the observed lack of cholera toxin binding are
discussed in section 5.7.2.
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FIG 5.0 12% SDS PAGE Gel Showing the Proteins Extracted From the Nuclear
envelope Extraction Procedure of Harris and Milne C1976).
A = Molecular weight markers
B = Nuclear envelope and associated proteins
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TABLE 5.0 Immunostainlng Protocol for Nitrocellulose Strips





























3 X 5 ml washes In PBS 1% BSA 2% TWEEN
60 mln at
37° C in 5ml
of
1/100 HRP labelled goat anti( rabbit IgG) antiserum
3 x 5 ml washes in PBS 1% BSA 2% TWEEN
Stained In
1 vol 3mg/ml 4-chloro-l-nspthol In methanol
+ 3 vol PBS + hydrogen peroxide(3pl/10mi buffer)
extensive washes In distilled water
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5.4.0 Binding of -^^I-labelled Cholera Toxin to Membranes
5.4.0.1 Direct Binding Assay
As the immunctolotting procedure failed to show cholera toxin binding, a
direct binding assay was done on the membranes as there was a strong
likelihood that the strongly denaturing conditions of the SDS PAGE or
absorption to the nitrocellulose blot had abolished the binding site or
that the binding site was just not available under these conditions.
A simple binding assay was carried out, similar to that performed by
Griffiths et al. (1986), to look at the properties of cholera toxin
binding sites on rabbit intestinal brush border membranes and the nuclear
envelope membranes.
Nuclear envelope membranes were diluted in 55mM Tris-HCl buffer containing
(80mM NaCl 10nM mannose 3mM K2HP04 ImM MgCl luM CaCl2 pH 7.4)
(Tris-buffer) to give a protein concentration from 10 to 650ug/ml.
Then 250ul of membrane suspension were aliquoted into 1ml Eppendorf tubes
which had previously been incubated with a 1% BSA solution to reduce
adsorption of radioactive toxin to the plastic tubes. The membranes were
then incubated with 50ul of diluted 125I-labelled cholera toxin (see
section 2.2.6) in the same buffer as the membranes to give an effective
toxin concentration of between 0.05-5.OOnM. All test samples were done in
duplicate. Control tubes had at least a 40 fold excess of unlabelled
toxin also. The tubes were then incubated in a 37°C water bath for one
hour. Following this, the tubes were centrifuged at 13 OOOg for 10 min in
a microfuge at room temperature and then the supernatant was removed.
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The pellets were then washed twice by resuspension and centrifugation at
13 OOOg (microfuge) in the Tris buffer. Finally, the radicactivity of the
pellets was counted in a gamma counter (1KB 1282). Brush-border membranes
from the same tissue (prepared and donated by David Longbottom),
Iongbottom and van Heyningen, (1989) were also included in the assay as
these membranes possess known cholera toxin binding sites (ganglioside
GM-jJ .
5.4.0.2 Binding Assay to Plastic Microtitre Plates
As the membrane binding assay used a large amount of membranes and
expensive amounts of cholera toxin, a microbinding assay was done which
meant binding could be done in triplicate and all reagents used in much
smaller volumes. Nuclear envelope membranes (0-50ul) of a 0.7mg/ml
solution were pipetted into the wells of a microtitre plate (Falcon
Microtest III) and the volume was made up to 50ul with lmM bicarbonate
buffer pH 7.6. The wells were covered and left overnight at 4°C. The
following day, the protein was removed and the wells were washed three
times with PBS containing 1% BSA and 0.05% Tween 20 (blocking buffer).
The wells were then filled with the blocking buffer and incubated for 2 hr
at room temperature. Then 50ul of an 18ug/ml 125I-labelled cholera
toxin solution (prepared as in section 2.2.6) was added to the wells then
incubated at room temperature for one hour. Controls included
pre-incubating the wells for 30 min with lmg/ml unlabelled cholera toxin,
or incubating the radioactive cholera toxin solution (18ug/ml) with 2mg of
GMj ganglioside for 30 minutes prior to labelling the wells.
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5.5.0 Adenylate Cyclase Assay and Marker Enzyme Assay
The nuclear envelope membranes were prepared twice by the same method
(Bloebel et al., 1966). As apparently specific cholera toxin binding was
observed with both preparations, it was necessary to show that there was
no significant plasma membrane contamination which might have produced a
false positive result. Therefore each of the preparations were tested for
one of two enzymes, thought to be specific for the plasma membrane. The
first preparation was subjected to an adenylate cyclase assay using the
method adapted from White (1974). The second preparation was tested using
the sucrase marker enzyme assay of Dahlqvist (1968). Both these assays
were kindly performed for me by a colleague, David longbottom of Edinburgh
University. The results are presented in sections 5.6.2 and 5.6.3
respectively.
5.6.0 Results
5.6.1 Direct Binding Data
Initial experiments with the first batch of nuclear envelope membrane were
repeated several times. The results presented are representative
experiments showing the mean of the duplicates (which did not differ more
that 10%), with non-specific binding allowed for by subtracting the values
obtained for the control which was always about 5% of the total counts
added (see Fig.5.1.a,b). The binding of cholera toxin appeared to reach
saturation at 6nM when the nuclear membrane protein concentration was
about 400ug/ml (see Fig. 5.l.c). In the other binding experiments shown
the membrane protein concentration (nuclear envelope) was also at 400ug/ml
or greater. It is apparent from the other binding curves that saturation
was not reached (Figs. 5.1a,b).
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Toxin concentrations above 5nM could not be used for all the experiments
performed as the cost of the toxin was prohibitive. An interesting point
to note is that the amount of toxin bound per microgram of protein is much
greater for the nuclear envelope preparation than for the brush-border
preparation. This result indicates that even if the nuclear envelope
preparation actually consisted of the same amount of plasma membrane
protein, this would not be enough to explain the extra binding capacity.
5.6.1.2 A Scatchard analysis of Binding
Toxin binding is thought to be multivalent which is likely as there are
five binding subunits (Fishman and Atikaan, 1979) and the binding is
essentially irreversible (K^ = 10~%) to plasma membranes of cells
possessing the GM, receptor, both factors which have to be considered if
one makes an analysis of the binding by a Scatchard plot. The analysis
assumes that all potential binding sites are equivalent which may not be
true for cholera toxin which can bind to up to five GM-^ ganglioside
molecules, and the probability of binding could change once the toxin is
already partially bound. The actual GM-^ molecules (or other binding
sites) are not necessarily the same either.
Despite the limitations of this analysis it was employed as a useful tool
to get one analysis of the type of binding that was observed with cholera
toxin on nuclear envelope preparations. A Scatchard analysis was
performed on the binding data from Fig.5.lb (Scatchard, 1949). The
Scatchard plot is presented in Fig. 5.2. The Scatchard plot is clearly
non-linear with a host of possible interpretations, one being an
indication of negative cooperativity, possibly representing two different
binding sites with different affinities for the toxin.
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Another explanation of the non-linearity of the Scatchard plot may be
that it represents a set of identical sites whose affinity decreases with
increasing receptor occupancy by the ligand (KLotz, 1986). In the
following analysis of the data the former binding model (two different
binding sites) was assumed. Again it must be stressed that this is the
simplest of interpretations of the plot. The major limitation with this
assumption is that saturation was not achieved and thus the binding
affinities especially the lower ones are extrapolated, a frequent
occurrence in Scatchard when it is rarely possible to perform binding
between 1% and 99% saturation which makes the plot more difficult to
interpret (Zierler, 1989). The binding model used to examine the binding
data may be represented by the following equation:
b = Nx.f / (K dl + f) + N2.f / (K^ + f)
b = concentration of bound ligand
Nlf N2 = concentrations of binding sites for site 1 and 2
%1' %2 = dissociation constants of each binding site for
ligand
f = concentration of free toxin
The above model was fitted to the experimental data using a program for a
non-linear regression written by Dr. G. Atkins of the Edinburgh
Biochemistry Department. The program was written in IMP and run on the
Amdahl 470 computers of the Edinburgh University Computing Service.
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The least squares procedure was that of Marquardt (1963). The data were
weighted equally. The Scatchard plot was useful for providing initial






(NB. The reaction mixture volume was 300ul and the protein
concentration was 400g/ml)








+/- (1 • 29riM)
+/- (66. lhM)
Therefore allowing for the volume of the binding reaction (300ul) the two
theoretical values may be about 2nM and 70nM respectively if indeed
there were two different binding sites (Note, however, the high standard
deviations on these figures). Taking the amount of cholera toxin bound,
1 ?
the total numbers of the two sites could be ^ = 4 x 10 sites per
milligram of protein and N2 = 6 x 1013 sites per milligram of protein
respectively.
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If the toxin was binding monovalently these numbers could represent the
total number of each type of binding site present. But as stated these
binding interpretations are just the simplest analysis of cholera toxin
and its binding to nuclear material because an alternative analysis of one
binding site which binds with increasing affinity to the toxin could
equally be true.
The result from the microtitre plate binding assay is represented by
Fig.5.3. This graph appears to be reaching saturation at about 55fmol
toxin pier well. As can be seen, preincubation of the toxin with GM-^
ganglioside abolished the binding. This experiment is discussed together
with the previous results in section 5.7.1.
5.6.2 Adenylate Cyclase Assay
The value obtained for the adenylate cyclase activity in the first
preparation of nuclear envelope and associated proteins was 0.056
pmol/min/mg protein). This result was measured losing the method of
Salamon (1979). In similar experiments with plasma membrane fractions
from the same intestinal tissue, David Iongbottom obtained values of 30
pmol/min/mg protein for the adenylate cyclase activity (the basal level
being less than 1). The difference in activity between the nuclear
preparation, and the plasma membrane preparation may indicate how little
plasma membrane contamination was present within the nuclear envelope
preparation.
However, adenylate cyclase is a readily inactivated enzyme. The nuclear
preparation was not 'flash' frozen in liquid nitrogen but at -20°C where
the possibility of ice crystal formation exists.
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Therefore, if adenylate cyclase had been present it might have been
inactivated by the freezing process.
5.6.3 Sucrase Enzyme Assay
The assay for sucrase (Dahlqvist, 1968) which is specific for plasma
membranes was kindly performed by David longbottom on both a nuclear
envelope preparation (2nd preparation) and a brush-border membrane
preparation from the same rabbit intestine. The membranes were kept on
ice and prepared on the same day and frozen in liquid nitrogen at the same
time. The results suggest that about a thirtieth of the nuclear
preparation is due to contamination from the brush-border preparation (see
table 5.1).
These results indicate very clearly the lack of contamination from the
brush-border membranes which contain known cholera toxin binding sites.
5.7.0 Discussion
5.7.1 Binding Data
These preliminary binding results strongly support the evidence for a
specific cholera toxin binding site in the nucleus.
The lack of saturation obtained may reflect a large number of lower
affinity sites present which is consistent with the Scatchard analysis (6
x 1013 sites per milligram of protein). The lack of saturation might
also represent internalisation of the toxin into nuclear membrane
vesicles.
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As the nuclear envelope preparation was not examined by electron
microscopy it is not known whether vesicles of membrane were actually
present, but Harris and Milne (1974) state that the nuclear envelope
preparation method does produce some intact nuclear ghosts. The binding
assay was performed at 37°C for one hour (a temperature at which
internalisation could take place).
Previous workers looking at cholera toxin binding in brush-border
membranes carried out the incubation at 0°C (Griffiths et al., 1986) or
in chicken intestinal cells, at 37°C (Hyun and Kimmich, 1984) and on
HeLa cells at 4°C and 37°C (Fishman and Atikaan, 1980).
Hyun and Kimmich (1984) stated that in their binding assay only 4% of
125j -labelled toxin binding could be reversed after 15 minutes
incubation at 37°C and that this represented the percentage of
internalised toxin into cells. They also analysed the stability of the
toxin receptors by pre-incubating the cells at 37°C before adding
125 j-iabeiied toxin to determine whether the nature of the binding
changed.
In my experiment I was dealing with nuclear membrane fragments and
associated heterochromatin. The possibility exists that nuclear membrane
vesicles were also present and that the lack of saturation represents
toxin being internalised into these vesicles. I did not determine the
binding at any other temperature, because I wanted to reproduce as much as
possible the binding conditions used in the electron microscopical binding
experiments (see section 4.4.2).
The K^ values of about 2nM for the possible high affinity site is the
same order of magnitude as previously calculated K^ values for cholera
toxin binding to GM-^ ganglioside (Cuatrecasas, 1973a; Donta et al.,
1982; Griffiths et al., 1986).
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The possibility that GM-^ exists in the nucleus is discussed in section
5.7.3. The binding of toxin to membrane was prevented by preincubation
with GM-^ ganglioside which further indicated that the binding site might
be GM-j^ ganglioside (see Fig.5.3).
The adenylate cyclase assay performed on the first nuclear preparation
suggests that these membranes did not contain plasma membrane
contamination. As the adenylate cyclase enzyme might have been destroyed
by the freezing process in the preparation of the membranes the lack of
contamination is not conclusive. Therefore the second preparation was
strictly temperature regulated and 'flash' frozen in liquid nitrogen to
maintain any potential enzyme activity.
The sucrase assay performed on this preparation clearly indicated that
only 3% of the nuclear envelope preparation was contamination by brash-
border membranes (see table 5.1). The binding site therefore was present
in the nuclear membranes.
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FIG 5.3 Microtitre plate binding assay for cholera
toxin to nuciear envelope membranes
membrane protein cone, pg/ml
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5.7.2 Tmmunoblottincr Data
The lack of binding indicated by the blotting technique (Section 5.3.1)
does not negate the iinraunocytochemical and direct binding assay results
both indicating the presence of a specific nuclear binding site for
cholera toxin.
There are many reasons why this technique did not show up a binding site.
Some of these are shewn below:
1) The binding site may have been reduced by the mercaptoethanol
treatment, so altering its conformation.
2) The site may be bound to the nitrocellulose and thus not available for
cholera toxin binding.
3) The SDS may have irreversibly denatured the binding conformation of
the site.
4) The binding site, if lipid (ie. GM^) might have been dispersed by
the detergent.
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H= CRUDE CELL HOMOGENATE
MPM= MIXED PLASMA MEMBRANES
BBM= BRUSH BORDER MEMBRANE PREPARATION
N= NUCLEAR ENVELOPE MEMBRANE PREPARATION
U=UNITS OF SUCRASE ACTIVITY
U/mg=SPECIFIC ACTIVITY
PF=PURIFICATION FACTOR COPARED TO CRUDE CELL HOMOGENATE
PROTEIN SUCRASE
CONC. ACTIVITY
MEMBRANE |ig/ml U/ml U/mg U
H 3.56 0.369 0.104 14
MPM 2.07 0.425 0.205 36.4
BBM 1.49 1.230 0.826 26.3
N 0.0625 0.0016 0.026 0.01
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5.7.3 Gancflioside Location Within the Nucleus
This subject was dealt with in chapter 4 but a few more points are made
here. The cellular location of gangliosides was mentioned in section
1.2.2.2. In an extensive review Franke (1974), indicated that no
glycolipids could be found in the nucleus in biochemical extractions
performed up till then.
Prior to the publication of this review, Keenan et al. (1972b), had
detected gangliosides within the nucleus, but judged this material to be
contamination, as it showed the same protein content as plasma membrane.
Later, Dnistran et al. (1979) also showed gangliosides to be present
within rat liver nuclei. They observed 1.00 nmol of glysophingolipid per
mg of protein in their nuclear fraction. This corresponds to about 6 x
1015 potential binding sites per mg of protein which is within two
orders of magnitude of one of ray calculated numbers of cholera toxin
binding sites. However, this calculation assumes all the glycophingolipid
sites to be GM^ ganglioside, which they are not (Dnistran et al., 1979).
More recently Matyas and Morre (1987) also detected gangliosides within
the nucleus of rat liver. They stated that 5% of total cell gangliosides
were detected within nuclei. Therefore, this evidence together with the
cholera toxin binding evidence presented in this study indicates the
existence of GM^ ganglioside within nuclei.
The possibility exists that there is a glycoprotein with a similar
carbohydrate composition to ganglioside GM-^. Both N-acetyl
galactosamine and N-acetyl glucosamine linked glycoproteins have been
found within the nucleus (Gerace et al., 1982; Snow et al., 1987).
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5.7.4 Physiological Relevance of Cholera Binding Site in the Nucleus
Previous work on cholera toxin internalisation into cells has not shown
cholera toxin to localise within the nucleus (Joseph et al., 1979; Janicot
and Desbuquois, 1987). However, Joseph et al. (1979) used the peroxidase
staining of cholera toxin which is difficult to observe within cells and
Janicot and Desbuquois (1987), detected 125I-labelled toxin which had
internalised after cell fractionation of liver, which was not a very
precise method to localise cholera toxin.
However, as cholera toxin was not expected to go to the nucleus it has
never been specifically looked for in this organelle.
In section 1.1.2 it was shown that some of the effects of cholera toxin in
cells cannot be correlated with increases in adenylate cyclase activity.
Recently Spiegel and Fishman (1987) looked at the effect of the B subunit
binding of cholera toxin to ganglioside GM^ and found that it both
stimulated ENA synthesis and cell division in quiescent, non-transformed
mouse 3T3 cells and inhibited the growth of ras transformed 3T3 cells.
They explain this result in terms of the role of GM-^ ganglioside and not
B subunit of cholera toxin.
They offer no mechanism by which the B subunit could modulate the growth
response of cells both positively and negatively. It could be that
binding of the B subunit to ganglioside GM-j^ affects the interaction of
the ganglioside with nuclear components.
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CHAPTER 6
CONCLUSIONS AND FUTURE WORK
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CHAPTER 6
OONCLUSIONS AND FUTURE WORK
6.0 Introduction
In this chapter the work presented in this thesis will be briefly
discussed with regard to the current theory of cholera toxin action on
cells and what is known about GM-^ ganglioside. In addition some further
experiments are suggested which might be performed to further address
those aspects of the toxin action and GM^ ganglioside function and
location which remain to be elucidated.
6.1 Cholera Toxin
6.1,1 Cholera Toxin Binding and Internalisation
As described in chapter one section 1.1.2 there are three basic steps to
intoxication by the cholera toxin protein and these are:
1. Binding of the toxin to the cell surface.
2. Internalisation of pari: or all of the toxin molecule.
3. Activation of the adenylate cyclase enzyme.
With regard to binding, there is overwhelming evidence that the toxin
binds predominantly to the GM-l ganglioside. It is known that the toxin
molecule is able to bind up to five GM-^ ganglioside molecules as it has
five B subunits each able to bind to one GMj ganglioside molecule.
However, it is not clear whether binding to one or more gangliosides is a
prerequisite for its further action.
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The next step is internalisation of the active A-j_ subunit of the toxin
from the extracellular surface towards the cytoplasmic surface where the G
protein of the adenylate cyclase enzyme complex is located. It is this
area which remains unclarified. It is known that binding of whole toxin to
GM-l ganglioside induces a conformational change in the toxin molecule as
measured by shift in the wavelength of tryptophan residues. Additionally,
toxin binding to lipid bilayers containing GM-j^ ganglioside perturbs the
lipid bilayer inducing pore formation. Furthermore, there is a lag time of
15-60 minutes between cholera toxin binding and onset of adenylate cyclase
activity. The variability in the lag time is due to different incubation
conditions (there is a temperature dependency) and different cell types.
The suggestion is that the lag time reflects a membrane translocation of
A^ subunit and at least four different mechanisms have been proposed
which are presented in chapter one, section 1.1.2.2. The final event is
the permanent activation of the adenylate cyclase enzyme.
In chapter 3 of this thesis the first measurements of the lateral mobility
of bound cholera toxin and additional lateral mobility measurements of its
cellular receptor GM-^ are presented. The receptor had been inserted into
the membrane of NIH 3T3 mouse fibroblasts which had their normal
complement of ganglioside <34^ in the membrane. The mobility of the
bound fluorescent toxin and of the inserted fluorescent ganglioside
receptor were similar with a lateral diffusion coefficient of
Q p _-l , , #
1x10 cm s and an immobile fraction of 20%. These results
indicate that lateral mobility is insensitive to size of the mobile
complex and that the bound toxin does not affect ganglioside mobility in
this cell line and that within the constraints of this type of physical
measurement there was no evidence of any other membrane phenomenon
occurring after toxin binding ie measurable patching which would have been
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indicated by increasing immobility of molecules with time. These
experiments also indicate that cholera toxin does not appear to cause
extensive crosslinking of GM-l receptor with immobile cell components. No
other conclusions may be drawn from these measurements of lateral
mobility.
There was uncertainty in the lateral mobility experiments performed as to
the binding pattern of the cholera toxin molecule. If a monomeric AB toxin
could be made, this could then be tested on the cell system for its affect
on lateral mobility of toxin and receptor or other combinations of A and
B. The A subunit could be linked to the B subunit by an easily cleaved
attachment eg. a disulphide bond. It is known that cellular mechanisms
exist to cleave the disulphide bond linking the active Aj peptide from
the A2 peptide, these might also act on the bond between the A and B
subunit. One could also perform the experiment linking the subunits by a
non cleavable bond, but such experiment might address more the question of
how the active component of the toxin reaches its site of action.
Internal isation of the toxin was not an area that was examined in this
thesis. In chapter 4 it was shown that the NIH 3T3 mouse fibroblasts used
in the lateral diffusion studies were able to internalise a gold-labelled
toxin probe but this experiment was used merely to show that cholera toxin
adsorbed to gold did not lose its ability to bind to cells and be
internalised.
Despite the fact that cholera toxin has been studied fairly intensively
over the last twenty years, as mentioned previously the precise mechanism
by which the A^ peptide reaches its site of action (the GTP binding
protein of adenylate cyclase) remains to be elucidated (see section
1.1.2.1).
197
It is clear there is a mechanism which exists in cells to internalise
whole toxin (sections 1.1.2.1; 4.3.1.2). There is a lack of experimental
data linking observations of internalisation of whole toxin or A-^
subunit alone with activation of adenylate cyclase. The major problem is
one of sensitivity (ie. detecting one cholera toxin molecule with
activity) and a continuous assay of the effect of toxin on a single cell
needs to be worked out. Such an experiment might employ the sensitive
• • • 0+ ,
fluorescent indicators of intracellular Ca 10ns, (Fura 1 and Fura 2).
There could be a correlation between the number of cholera toxin molecules
bound and the increase in intracellular calcium concentration. Dixon et
al. (1987) showed that the growth stimulatory effects on rat lymphocytes
• ... OJ. ,
of the B subunit alone are mediated by an increase in [Ca ]; resulting
from a net influx of extracellular calcium. This cellular model could
then be probed with the sensitive post-embedding immunogold technique to
localise whole toxin and individual subunits too. The combination of two
such experiments would provide an insight in the numbers of molecule which
bind to and/or get internalised into a cell but it would then have to be
linked to a further experiment in the same cell on levels of toxin
required for activation of adenylate cyclase.
Both sets of experiment which determine a relationship between toxin
binding and internalisation and toxin binding and adenylate cyclase
activation would have to be performed under strictly the same conditions
of temperature and media to allow a link to be made between the amount of
toxin binding and amount of adenylate cyclase activation in the cell. Such
experiments would have been performed had they been easy, but immunogold
localisation of internalised molecules is still difficult to perform in
itself and it may take a long time to optimise conditions of localisation
within cells.
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Adenylate cyclase activity studies are also very difficult to perform
consistently. It may be however that there is no specific mechanism for
internalisation and cholera toxin gets to its site of action by being
attached to GM-^ ganglioside and exploiting its internalisation route.
6.1.2 Cholera Toxin Novel Binding Site/Intracellular Localisation of
GM^ Gamlioside
Experiments performed in this study suggest the possible nuclear location
of GM-l ganglioside (section 4.3.2.1; publication at end of thesis).
This binding site must be GM^ or a very similar molecule as all the
controls performed point strongly toward this interpretation of the
binding of the toxin.
One of the other possible interpretations of this observation of a nuclear
binding site could be that a nuclear glycoprotein with a very similar
carbohydrate moiety to GM-^ ganglioside is located in the heterochramatin
of the nucleus. There is no evidence to show that cholera toxin does
reach the nucleus of cells on which it acts but the above finding should
be further examined to see whether toxin does affect any nuclear functions
and the nucleus should also be further examined and analysed for GM-l
ganglioside.
The function of the unreported toxin binding site (sections 4.3.2.1;
5.6.0) might be further investigated by doing some simple activity studies
with intact nuclei (prepared by the method of Bloebel and Potter, 1966).
One could examine whether intact cholera toxin or the B subunit of the
toxin affects nuclear ADP ribosylation or another nuclear process. Again,
the sensitive post-embedding immunogold technique could be used to
localise internalised toxin molecules inside individual nuclei.
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Precise biochemical analysis of nuclear fractions should be performed,
perhaps by High Performance Liquid Chromatography; with ganglioside
molecules as standards to examine the existence of such molecules in this
cellular organelle. The major problem with extracting nuclei is that the
procedure also allows contaminating cellular membranes to be extracted
with the nuclei and this problem has to be overcome before a definitive
answer can be sought.
6.2 GM]^ Gancrlioside
Gangliosides are being increasingly studied, probably because of their
possible involvement as cell surface markers for oncogenesis (section
1.2.3.2). They remain molecules whose structures have been elucidated but
whose functions remain unknown.
6.2.1 GM^ lateral mobility
The mobility of ganglioside GM^ has been demonstrated on several cell
types, (see table 3.1). In experiments described in this study GM^
ganglioside mobility has also been demonstrated (see section 3.5.2).
However, a new technique has emerged which allows individual cell
components to be examined. This technique is 'nanovid tracking' (Geerts et
al. 1987) (nanovid = nanopartide video microscopy). This technique
enables the experimenter to follow the motion of individual colloidal gold
markers on the cell.
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If the colloidal gold were adsorbed onto a Fab fragment of a monoclonal
antibody, specific for GM-^ ganglioside, then it follows that the motion
of individual GM-^ ganglioside molecules on the cell could be observed.
This procedure would also allow the fraction of mobile and immobile GM-^
ganglioside molecules to be examined.
6.2.2 Gancflioside Clusters
The existence of ganglioside clusters (section 3.6.2) needs to be further
examined. Immunogold surface replica studies using a specific
anti-ganglioside GM^ antibody should be carried out. One might also be
able to determine whether gangl iosides exist as clusters by the use of
photoactive cross-linking agents. Such agents were used to determine how
far the subunits of cholera toxin penetrated the lipid bilayer of an
artificial system (Wisnieski and Bramhall, 1981).
The work presented in this thesis shows how powerful a tool cholera toxin
is for examining the location and possible function of GM-l ganglioside
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Localisation of a Cholera Toxin Binding Component in the
Nuclei of Mouse Intestinal Cells by the Post Embedding
Immunogold Technique.
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ABSTRACT
A cholera toxin binding component (probably GM1 Ganglioside) has been located in the chromatin
of intestinal cell nuclei. Cholera toxin binds with high affinity (Kd=10~9M) and specificity to
ganglioside GM1. Localisation involved a sandwich of cholera toxin, antitoxin antibody and gold
labelled second antibody on mouse intestine, previously embedded in hydrophilic resin. There was a
sparse distribution of gold amongst the microvilli, clusters in the cytoplasm, in vesicle-like
structures and most surprisingly, a distribution of gold accross the chromatin of the nuclei. All
binding could be abolished by preincubating the toxin with ganglioside GM1. Anti-GM1 antibody also
bound to the nucleus, indicating the presence of the ganglioside or a similar molecule in the nucleus.
KEYWORDS
cholera toxin, GM1 ganglioside, mouse intestine, post embedding immunogold
INTRODUCTION
Previous studies on the immunocytochemical localisation of GM1 ganglioside used peroxidase
conjugated anti-cholera toxin antibody (Hansson, 1977), or the preembedding immunogold
technique (Ackerman, 1980). However, both these studies have concentrated on the external GM1
molecules located at the outer surface of the plasma membrane. The only evidence for the
intracellular location of GM1 has been demonstrated by biochemical fractionation techniques
(Keenan, 1972). Cholera toxin has been shown to bind to GM1 almost exclusively, on the cell
surface (Hollenberg,1974). Therefore cholera toxin is a natural probe for GM1 ganglioside and
using it to locate GM1 intracellular^ may give some indication of the physiological role of the
ganglioside. Some gangliosides have altered expression in cancer cells (Feizi, 1985) implicating
them in growth regulation. Recently, it has been shown, using cholera toxin B subunit (the
ganglioside binding site), that the ganglioside may be a bimodal growth regulator of cells, acting
synergistically with EGF (Speigel, 1987). Therefore, the possible location of GM1 ganglioside in
the nuclei of mouse intestinal cells may reflect some aspect of this physiologically observed action.
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RESULTS
Fig. 1. The binding of the B subunit of cholera toxin Fig.2. The binding of anti-GM1 antibody
(1 (a.g/ml in Dulbeocos PBS pH 7.4) (1/100 in PBS buffer)
The results indicate that the predominant binding site for the cholera toxin is the heterochromatin
near the nuclear envelope. Prior treatment with pronase abolishes this chromatin binding site.
Preabsorption of the toxin with GM1 ganglioside abolishes all binding on both the nucleus and
microvilli. Further work is underway to identify this cholera toxin binding component within the
nucleus.
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Identification of cholera toxin-binding sites in the nucleus of
intestinal epithelial cells
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Post-embedding immunogold electron microscopy shows several binding sites for cholera toxin in mouse intestinal epithe¬
lial cells, particularly in the heterochromatin of the nucleus as well as in the plasma membrane. Anti-ganglioside GM1
antibodies also bound to the nucleus, but did not interfere with the binding of toxin. 125I-labelled toxin bound specifically
to a nuclear preparation from rabbit intestinal cells.
Cholera toxin; Immunogold; Heterochromatin; Ganglioside GM1; (Nucleus)
1. INTRODUCTION
Cholera toxin (Mr 84000, for general review see
[1]) is composed of one A subunit and five B
subunits. The B subunits bind to the outer mem¬
brane of cells and, by a mechanism not yet
understood, this leads to the entry into the cell of
the A1 polypeptide of the A subunit which ac¬
tivates adenylate cyclase by catalysing the ADP-
ribosylation of the regulatory Gs protein. The
binding of the B subunits is almost exclusively to
ganglioside GM1 in the outer membrane. Binding
is tight (A"d = 10~9 M) and specific: cholera toxin
has often been used as a marker for ganglioside
GM1.
Previous studies in which the ganglioside GM1
was localized immunocytochemically have used
toxin incubated with cells, followed by labelling
with peroxidase-conjugated antitoxin [2] or with
immunogold [3,4] before embedding. They have
shown ganglioside GM1 only on the external
membrane.
Correspondence address: S. van Heyningen, Department of
Biochemistry, University of Edinburgh, Hugh Robson
Building, George Square, Edinburgh EH8 9XD, Scotland
In the experiments described in this paper we
used the post-embedding immunogold method [5]
to investigate binding sites for cholera toxin in
epithelial cells of mouse small intestine. Labelling
under these conditions shows binding sites (both
intra- and extracellular) that are available to the
toxin after the tissue had been fixed and sectioned:
this does not imply that such sites would be accessi¬
ble to the toxin in intact cells or in vivo. This
technique has been used previously, for example,
in investigating the intracellular localization of
regulatory polypeptides [6]. We found binding
sites for the toxin in the microvilli, in the plasma
membrane, and in the heterochromatin of the
nucleus.
2. MATERIALS AND METHODS
2.1. Preparation of tissue for electron microscopy
Small pieces of freshly excised mouse small intestine were fix¬
ed in 1% paraformaldehyde, 0.05% glutaraldehyde, 0.15 M
NaCl, 50 mM phosphate buffer, pH 7.4, for 2 h at 4°C, washed
in this buffer overnight at 4°C, dehydrated through ethanol;
and embedded in hydrophilic resin (3 parts LR gold resin, Lon¬
don Resin Co.; 2 parts glycol methacrylate low acid, and 0.01%
benzoin ethyl ester, Polysciences). The resin was polymerized
Published by Elsevier Science Publishers B. V. (Biomedical Division)
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by ultra-violet radiation (360 nm) for 24 h at room
temperature.
2.2. Immunolabelling
Ultrathin sections mounted on collodion-coated nickel grids
were incubated with 0.5 M NH4CI, in a buffer containing
0.15 M NaCl, 50 mM phosphate, pH 7.0, for 1 h at room
temperature to block free aldehyde groups; washed with several
changes of buffer, and incubated first for 30 min in 1 mg/ml
ovalbumin, and then for 30 min in 850 ng/ml cholera toxin
(supplied by Sigma, and used at a concentration chosen ex¬
perimentally to give specific labelling and a very low
background). After several washes in buffer, they were in¬
cubated for 1 h in rabbit anti-(cholera toxin) serum [6] (diluted
250 times in the buffer), washed again and finally incubated for
30 min with goat anti-(rabbit IgG) labelled with 15 nm gold
(Janssen Pharmaceuticals) diluted fifty times. All incubations
were at 37°C. After further washings in buffer and then in
water, the grids were counterstained in 2% uranyl acetate and
lead citrate, and examined with a Jeol 100CX2 electron
microscope.
2.3. Preparation of a nuclear fraction
Nuclei were prepared from rabbit intestinal epithelial cells
(prepared from gut scrapings) by the method of Bloebel and
Potter [8]. A preparation of nuclear envelope with associated
heterochromatin was prepared from this by the method of Har¬
ris and Milne [9]. It was analysed by polyacrylamide gel elec¬
trophoresis in the presence of SDS, and shown to have the
expected protein profile [10]. The plasma membrane-marker
enzyme sucrase was assayed by the method of Dahlqvist [11],
2.4. Measurement of toxin binding
Cholera toxin was iodinated using chloramine-T [12], and
used at about 70 GBq/,«mol. its binding to the nuclear prepara¬
tion was measured essentially as described by Griffiths et al.
[13] except that the buffer was 55 mM Tris-HCl, 80 mM NaCl,
10 mM mannose, 3 mM K2HPO4, 1 mM MgCL, 1 mM CaCb,
pH 7.4. 250 fA of the nuclear preparation (400 /*g/ml) were used
for each triplicate determination. Controls using a forty-fold
excess of unlabelled toxin were subtracted from experimental
data. All duplicates showed less than 10% variation.
3. RESULTS
3.1. Post-embedding immunogold electron
microscopy
Some results from the experiments designed to
show binding sites for cholera toxin are shown in
fig.l. There are two major sites, together with
some low levels of binding elsewhere in the cell,
e.g. to vesicular structures (perhaps lysosomes and
coated vesicles) in the cytoplasm. As would have
been predicted from earlier work, there was exten¬
sive binding of whole toxin or of isolated subunit
310
Volume 242, number 2 FEBS LETTERS January 1989
B to the plasma membrane and microvilli (as
shown in fig.la). More surprisingly, under the
same experimental conditions, there was a heavy
distribution of colloidal gold on the hetero-
chromatin of the nuclei (fig.lb). These ex¬
periments were done with many different samples,
b
and in all cases the major binding was to the
plasma membrane and to the nucleus.
Controls were carried out to show that the
observed nuclear binding was specific for toxin,
and not, for example, to non-specific binding of
the antibodies used in the immunogold labelling.
Fig.l. Electron micrographs of sectioned mouse intestinal tissue treated post-embedding with cholera toxin and immunogold. (a)
Microvilli treated with 850 ng/ml whole toxin; (b) nuclei from the basal end of adjacent epithelial cells treated with 1 /.<g/ml subunit
B. Bars are 1 pm long.
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No gold was observed to bind to the nucleus or to
the microvilli when (i) the rabbit antitoxin had
been preadsorbed with toxin; (ii) cholera toxin was
omitted; (iii) rabbit antitoxin was omitted; and (iv)
the incubation was done with gold-labelled second
antibody alone without toxin or second antibody.
Essentially identical binding was observed
following similar experiments with rat intestinal
cells.
3.2. Are the binding sites ganglioside GM1?
Several experiments were performed in order to
find out whether the binding sites in the nuclei
were ganglioside GM1. For example, toxin that
had been preincubated with a 2 X 105-fold molar
excess of ganglioside failed to bind, presumably
because the binding site on the toxin was no longer
available (although conceivably because of
transmitted conformational change to a different
binding site). Binding experiments done not with
toxin but with a polyclonal anti-GMl antibody
preparation (kindly given to us by Dr N. Gregson
of Guy's Hospital, London) gave very similar
results to those found with toxin, suggesting a
similar distribution of ganglioside and toxin-
binding sites. However, preincubation of the post-
embedded tissue with this antibody did not inhibit
subsequent binding of toxin, nor did preincubation
with toxin inhibit binding of antibody.
3.3. Biochemical measurement of binding
In order to verify that there are toxin-binding
sites present in the nucleus, direct binding ex¬
periments were performed using 125I-labelled toxin
and a preparation of nuclear envelope from rabbit
intestine.
Fig.2 shows a measurement of the binding of
125I-labelled toxin to this preparation: the results
are corrected for non-specific binding. Analysis of
these data shows that they are compatible with a
model in which there are about 4 X 1012 high-
affinity binding sites (Kd about 2 nM) per mg pro¬
tein, and about 6 x 1013 per mg of lower affinity
(A'd about 70 nM).
Preliminary binding experiments using nuclear
proteins adsorbed to microtitre plates gave similar
results, and binding was abolished when the toxin
was preincubated with ganglioside GM1. In order
to establish the degree of contamination of the
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Fig.2. Binding of 125I-labelled whole cholera toxin to a nuclear
preparation from rabbit intestinal cells, corrected for non¬
specific binding.
assayed for sucrase (a marker enzyme for the
plasma membrane). The activity suggested that
contamination could not have been more than 3%
of the protein in the preparation; quite inadequate
to account for the toxin binding. Efforts to iden¬
tify a specific binding protein by 'Western blot'
analysis of the membrane preparation were not
successful.
4. DISCUSSION
The experiments reported in this paper showed
potential binding sites for cholera toxin associated
with the nucleus. It seems likely that these sites are
ganglioside GM1, the only receptor for the toxin
that has been positively identified. This conclusion
is supported by our observation that the binding is
inhibited when toxin is preincubated with
ganglioside and that the distribution in the cell of
sites that bind anti-GMl antibodies parallels that
of toxin-binding sites. It is true that these an¬
tibodies did not interfere with the binding of toxin,
but that could be easily explained if, as is probable,
the affinity of the antibody for GM1 is lower than
that of the toxin, or if the anti-GMl does not bind
to all the possible sites.
It is still possible, however, that the binding site
is not a ganglioside, but, for example, a glycopro-
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tein with a similar structure. Evidence from cell
fractionation experiments, e.g. [14] has shown
gangliosides in some intracellular membranes, but
has usually been interpreted as showing no sign of
gangliosides in the nucleus. On the other hand,
binding of cholera toxin is probably the most sen¬
sitive available probe for ganglioside GM1.
Our experiments do not imply that these
nuclear-binding sites can be reached by the toxin
when it is working in the intact cell or in vivo, nor
do they in themselves suggest any physiological
role for binding to the nucleus.
Experiments on internalization of peroxidase-
conjugated or 125I-labelled toxin into intact cells
have shown the toxin to be associated with a
number of intracellular organelles, e.g. the Golgi
complex [15] and other intracellular vesicles [16].
There has been no evidence for any particular
binding to the nucleus. There is evidence, however,
that gangliosides can be associated with cell growth
and differentiation and so perhaps with gene ex¬
pression in the nucleus. For example, Spiegel and
Fishman [17] have shown that the interaction of
the B subunit of cholera toxin with ganglioside
GM1 can act as a bimodal growth regulator of
cells, acting synergistically with epidermal growth
factor.
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